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ABSTRACT
Purpose.
This dissertation research sought to determine whether the proportion of
physicians using electronic prescribing (e-prescribing) was associated with the
hospitalization rate for adverse drug events (ADEs) among patients aged 65 and older in
2011. Additionally, we sought to determine whether increases in the proportion of eprescribing physicians in a county were associated with decreases in the hospitalization
rate for ADE among older adults.
Methods.
Two study designs were used, a cross-sectional study using 2011 data and a prepost- study using 2008 and 2011 data. Data from the 2008 and 2011 State Inpatient
Databases, the Office of the National Coordinator Health IT Dashboard, and the Area
Health Resource File were gathered for six states: Arizona, Florida, Maryland, Michigan,
New Jersey, and Washington. ADE hospitalization rates were calculated for adults 65
years and older. The independent variable, the rate of e-prescribing, was an ecological
measure for both analyses. Multivariable linear regression examined county rates of ADE
hospitalization in 2011, multivariable logistic regression examined the odds that a
discharge would have been ADE associated versus other causes in 2011, and negative
binomial regression was used to model the ADE hospitalization rate among older adults
in 2011 based on the ADE hospitalization rate in 2008, the change in e-prescribing rates,
and county characteristics.
v

Results.
Results indicated that county e-prescribing rates were not significantly associated
with county ADE hospitalization rates among older adults (p=0.4705). Further, after
adjusting for patient, provider, health infrastructure, and community factors, the county eprescribing rate was not a significant factor in determining the odds of an ADE
hospitalization. Change in e-prescribing rates was not significantly associated with the
change in ADE hospitalization rates; no other county characteristics were found to be
significant factors.
Conclusion.
Though the adoption of e-prescribing has continued to increase throughout the
U.S., our findings indicate that population-level benefits, such as decreased ADE
hospitalization among older adults, have yet to be seen. It may be too early to detect
population-level changes due to low levels of implementation of health information
technologies, such as e-prescribing. Researchers and policy makers must continue to
monitor the population impact that the implementation of HITs is having on the health of
the nation.
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CHAPTER 1
INTRODUCTION
Focusing on improving patient safety and the quality of health care provision in
the United States, the Institute of Medicine (IOM) has published To Err is Human:
Building A Safer Health System (1999) and Preventing Medication Errors: Crossing the
Quality Chasm Series (2007). Both reports discussed and provided potential strategies to
reduce medication errors, adverse drug events, and/or potential drug events (Institute of
Medicine, 1999, 2007). One such strategy is electronic prescribing (e-prescribing)
defined as an electronic transmission of “an accurate, error-free and understandable
prescription directly to a pharmacy from a point-of-care” (Centers for Medicare and
Medicaid Services, 2014).
Several key pieces of legislation during the past two decades have encouraged the
adoption of e-prescribing by health care providers. The initial movement toward adoption
of e-prescribing began with the Medicare Modernization Act (MMA) of 2003 and the
2007 IOM report, Preventing Medication Errors: Crossing the Quality Chasm Series
(Centers for Medicare and Medicaid Services, 2014). In 2008, Section 132 of the
Medicare Improvements for Patients and Providers Act (MIPPA) created an incentive
program for eligible professionals that were electronic prescribers. Most recently the
Health Information Technology for Economic and Clinical Health (HITECH) Act, part of
the American Recovery and Reinvestment Act (ARRA) of 2009 created the Medicaid and
Medicaid EHR Incentive Programs to be administered by the Centers for Medicare and
1

Medicaid Services (CMS) for the “meaningful use” of health information technology
(HIT), including e-prescribing capabilities (Centers for Medicare and Medicaid Services,
2010).
Billions of dollars are being spent to aide physicians in the adoption of health
information technologies. There has been a significant increase from 33% physicians
adoption e-prescribing in 2009 to 73% of physicians in 2012 (King, Patel, & Furukawa,
2012). It is essential that we demonstrate the impact of the adoption of e-prescribing on
patient outcomes.
Adverse drug events (ADEs) occur when prescription medications cause patient
injury or harm. ADEs have public health importance because of the high numbers of
Americans taking prescription drugs, particularly older Americans. During 2007-2010,
approximately 40% of Americans aged 65 years and over managed five or more
prescription drugs in the past 30 days; an increase from 28% during 1999-2002 (U.S.
Food and Drug Administration, 2013b). In the past decade the Food and Drug
Administration Adverse Event Reporting System (FAERS) reports a continued increase
in the number of reported adverse drug events (U.S. Food and Drug Administration,
2013b) and serious patient outcomes (U.S. Food and Drug Administration, 2013a).
Researchers have also seen an increase in ADEs over time (Bourgeois, Shannon, Valim,
& Mandl, 2010; Budnitz et al., 2006). The number of ADEs reported in U.S. hospitals
increased 52% between the years of 2004 and 2008 (Lucado, Paez, & Elixhauser, 2011).
ADEs are seen among older adults nearly 7 times more often than among adults
younger than 65 years (Budnitz et al., 2006). In this patient population, ADEs are an
important indicator of patient safety. These adverse events have been associated with an
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increase in the length of hospitalization, resource utilization, expense, and risk of
mortality (Budnitz et al., 2006; Classen, Pestotnik, Evans, Lloyd, & Burke, 1997; Field et
al., 2005). Recent estimates suggest that approximately 99,600 older adults are
hospitalized each year due to ADEs (Budnitz, Lovegrove, Shehab, & Richards, 2011).
As the number of providers that e-prescribe and exchange clinical health
information continues to rise, it is important to evaluate the impact these changes are
having on patient outcomes, such as ADEs. The literature on the impact of health
information technologies on ADEs is still in its infancy. The majority of literature in this
area is conducted within inpatient settings and lack generalizability. The proposed study
provides a population-based approach to examine the association of e-prescribing
community-based physicians on ADE hospitalizations among older Americans (age 65
and older). The specific aims of the study are: 1) determine the relationship between the
percentage of physicians in a county using electronic prescribing (e-prescribing) and
county-level rates of ADE hospitalizations among patients 65 years and older; and 2)
determine the association between 2008 – 2011 change in percentage of physicians using
electronic prescribing (e-prescribing) and change in county-level rates of ADE
hospitalizations among patients 65 years and older. It is anticipated that a higher
percentage of e-prescribing physicians will be associated with a lower rate of ADE
hospitalization among the population of interest.
This dissertation is formatted using the manuscript style; Chapters 4 (Results) and
5 (Conclusions) will be replaced with two manuscripts representing the two specific aims
examined. Chapter 2 provides a review of scholarly literature in patient safety indicators,
health information technologies, e-prescribing, and previous research in that examines the
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intersection of health information technology and patient safety. Chapter 3 provides an
overview of the methodology utilized to examine the two study aims of this dissertation
research. Chapter 4 explores the association between electronic prescribing and adverse
drug event hospitalization rates at a cross-sectional ecological and discharge-level, while
Chapter 5 explores a similar association but examines the change between 2008 and
2011. Chapter 6 provides a highlight of major findings from this dissertation.
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CHAPTER 2
LITERATURE REVIEW
National Focus on Quality and Patient Safety
For several decades, healthcare has focused on providing quality care and
ensuring patient safety. The 1999 Institute of Medicine (IOM) report, To Err Is Human,
illustrated the need for a safer healthcare system. The report estimated between 44,000
and 98,000 patients die as a result of medical errors each year (Institute of Medicine,
1999). This estimate landed medical errors among the top 10 leading causes of death in
the United States and costs the healthcare system between $17 billion and $29 billion. To
Err Is Human provided several recommendations to decrease the number of medical
errors occurring in the U.S. healthcare system (Institute of Medicine, 1999). These
recommendations centered around: establishing a national focus on patient safety;
identifying and learning from medical errors; creating standards for improvements in
patient safety; and implementing safe practices in health care delivery systems.
Two years later, the IOM released another report, Crossing the Quality Chasm: A
New Health System for the 21st Century (Institute of Medicine, 2001). This report stressed
the importance of building our healthcare system around six areas: safety, effectiveness,
patient-centeredness, timeliness, efficiency, and equity. The report also stressed the
importance of changing the environment of healthcare to: 1) apply evidence to healthcare
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delivery; 2) use information technology; 3) align payment policies with quality
improvement; and 4) prepare the workforce.
These IOM reports initiated focus on healthcare quality and patient safety that
continues today. Several other reports by the IOM, Patient Safety: Achieving a New
Standard of Care, Preventing Medication Errors: Quality Chasm Series, and Health IT
and Patient Safety: Building Safer Systems for Better Care continued to emphasize
quality improvement and patient safety in the U.S. healthcare system.
Reinforcing the goals and recommendations of the IOM reports is the Triple Aim
of healthcare: improving the care experience, improving population health, and reducing
per capita healthcare costs (Berwick, Nolan, & Whittington, 2008). These three aims are
interdependent; changes in pursuing one aim can impact the other aims. Though quality
and patient safety are not explicitly named in the Triple Aim, improvements in each aim,
without negatively impacting other aims, requires a focus on quality and patient safety.
For example, to reduce the per capita healthcare costs without a decline in the patient care
experience requires improvements in processes that reduce waste. Strategies to reducing
waste address: failures of care delivery, failures of care coordination, overtreatment,
administrative complexity, pricing failures, and fraud and abuse (Berwick & Hackbarth,
2012). Eliminating waste in any of these categories results in an increase in quality and/or
patient safety.
For nearly two decades, the U.S. healthcare system has continued to focus on both
quality and patient safety. As advances in science and technology continue at exponential
rates, it becomes impossible to comprehend and retain this information (Cobb, 2004;
Institute of Medicine, 2001). Additionally, between the large patient populations for
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which each physician cares and the ever-increasing number of available prescription
drugs, providers are unable to remember all drugs each patient is taking and what
potential drug-drug or drug-allergy interactions for which each patient could be at risk.
Considering that information plays a key role in the reduction of errors and it is crucial
for clinicians to stay current with advances, the potential role of health information
technology holds much promise (Cobb, 2004; Einbinder & Bates, 2007).
Patient Safety – Adverse Drug Events
Definitions
Various terms describe specific types of medication errors; commonly used terms
are defined and referenced in Table 2.1. A visual representation of the relationship
between the terms is also provided below in Figure 2.1. Medication errors and adverse
drug events (ADEs) can have multiple sources that range from practice, products,
procedures, and systems (Institute of Medicine, 2007). In the universe of all prescriptions,
half of prescriptions are reported to have some type of error; most of which do not result
in harm (Lisby, Nielsen, & Mainz, 2005; “Suggested definitions and relationships among
medication misadventures, medication errors, adverse drug events, and adverse drug
reactions.,” 1998). ADEs, defined as injuries that are the result of medication, fall into
two categories: nonpreventable ADEs (also referred to as adverse drug reactions in the
health services research literature) and preventable ADEs. Preventable ADEs may or may
not result in harm. Preventable ADEs can be prevented through various error reducing
practices. Some preventable ADEs and nonpreventable ADEs have serious consequences
(“Suggested definitions and relationships among medication misadventures, medication
errors, adverse drug events, and adverse drug reactions.,” 1998). An example of a
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preventable ADE would be an incorrect medication dosage that leads to patient harm or
injury. Nonpreventable ADEs are unanticipated drug effects. An example of a
nonpreventable ADE would be an allergic reaction in a patient not known to have an
allergy (Institute of Medicine, 2007).
Table 2.1 Key terms utilized in healthcare medication error literature
Terms
Source
Definition
(D. Bates, Cullen, &
“any error occurring in the medication use
Laird, 1995)
process”
(National
“any preventable event that may cause or
Medication
Coordinating Council lead to inappropriate medication use or
Error
for Medication Error
patient harm while the medication is in the
Reporting and
control of the health care professional,
Prevention, 2014b)
patient, or consumer.”
(Institute of
“an injury resulting from medical
Medicine, 1999)
intervention related to a drug”
Adverse Drug
(Cresswell, Fernando, “an unwanted occurrence after exposure to a
Event (ADE)
McKinstry, & Sheikh, drug that is not necessarily caused by the
2007)
drug”
(D. Bates et al., 1995) “any injury due to medication”
Preventable
(Institute of
“an adverse event attributable to error”
Adverse Event Medicine, 1999)
Nonpreventable
Adverse Drug
“any undesirable effect of a drug beyond its
Event (also
(Cresswell et al.,
anticipated therapeutic effects occurring
referred to as
2007)
during clinical use”
Adverse Drug
Reaction)
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Figure 2.1 Relationship between medication errors and adverse drug events
ADEs are of particular public health importance because of the high numbers of
Americans taking prescription drugs, particularly older Americans. Across 2007-2010,
approximately 40% of Americans aged 65 years and over used five or more prescription
drugs in the past 30 days; an increase from 28% during 1999-2002 (U.S. Food and Drug
Administration, 2013b). The Food and Drug Administration Adverse Event Reporting
System (FAERS) has seen a continued increase in the number of reported adverse events
and serious patient outcomes in the past decade (U.S. Food and Drug Administration,
2013a). ADEs are seen in older adults nearly 7 times more often than among adults
younger than 65 years (Lucado, Paez, & Elixhauser, 2011). These ADEs result in over
half (53%) of all inpatient stays with a drug-related adverse outcome among this age
9

group (Lucado et al., 2011). In this patient population, ADEs are an important indicator
of patient safety. These adverse events have been associated with an increase in the
length of hospitalization, resource utilization, expense, and risk of mortality (Daniel S
Budnitz et al., 2006; Classen, Pestotnik, Evans, Lloyd, & Burke, 1997; Field et al., 2005;
Hug, Keohane, Seger, Yoon, & Bates, 2012). Recent estimates suggest that between
100,000 to 200,000 older adults are hospitalized each year for ADEs (D S Budnitz,
Shehab, Kegler, & Richards, 2007; Gabriel, Furukawa, & Vaidya, 2013).
Estimates of ADEs
Literature on ADE estimates focus on several settings: within hospitalization
stays, emergency department visits, emergency department visits leading to
hospitalization, and outpatient office visits. Between 1.4% to 41.4% of patients
experience an ADE while hospitalized (Cano & Rozenfeld, 2009; Senst et al., 2001).
However, ADEs are more likely to be present on admission than to originate during a
hospital stay (Weiss, Elixhauser, Bae, & Encinosa, 2013). Approximately 12% of
emergency department visits are estimated to be due to ADEs (Zed et al., 2008)(Yee,
Hasson, & Schreiber, 2005). Only a small percentage (<1%) of drug-related emergency
department visits are treat-and-release visits (Lucado et al., 2011). Of all hospital stays
that were the result of an emergency department visit, it is estimated that between 2.4%
and 9.0% are caused by ADEs (D. Bates et al., 1995; Daniel S Budnitz et al., 2005;
Kaushal, Barker, & Bates, 2001; Leape et al., 1991; Lucado et al., 2011; Moore,
Lecointre, Noblet, & Mabille, 1998; Senst et al., 2001; von Laue, Schwappach, & Koeck,
2003). Senst et al. (2001) found that over three-fourths (76%) of ADE-related hospital
admissions were preventable. The literature on outpatient visits due to ADEs is sparse;
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the few studies conducted in this setting estimate that 5.0-5.5 per 100 person-years are
due to ADEs (Gurwitz et al., 2003; Honigman et al., 2001).
Potential Causes of ADEs
Several different factors contribute to the hospitalization of older adults for ADEs
(Cresswell et al., 2007). The most cited potential causes include polypharmacy and/or
polymedicine, traits of older adults that increase their susceptibility to ADEs,
unnecessary or inappropriate use of medications, lack of communication between
multiple providers, among others.
The most cited reason is polypharmacy and/or polymedicine. Polypharmacy is
defined as the “use of multiple medications and/or administration of more medication
than are clinically indicated” (Parsons, Lapane, Kerse, & Hughes, 2011). Polymedicine is
defined as the “increasing number of medications related to a similarly increasing number
of medical problems” (Pham & Dickman, 2007). Both polypharmacy and polymedicine
shed light on the increased number of medications taken by this age group and the
potential for them to cause ADEs (Bourgeois, Shannon, Valim, & Mandl, 2010; Y.-C.
Chen et al., 2014; Lattanzio et al., 2012; Malhotra, Karan, Pandhi, & Jain, 2001; ZA
Marcum et al., 2012; Martínez-Cengotitabengoa, Besga, Fernández, Micó, & GonzálezPinto, 2011; Olivier et al., 2009; Parsons et al., 2011; Roulet et al., 2014; Stuck et al.,
1994). One study, conducted by Nickel et al. (2013), estimates that each additional drug
taken by an individual accounted for a 10% increase in probability of suffering from a
drug-related problem. In addition to the increased use of pharmaceuticals in our country,
the unique characteristics of the older population may contribute to their increased rate of
ADE hospitalizations (Daniel S Budnitz et al., 2006; Salvi et al., 2012). Older adults are
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the most likely age group to require hospitalizations of any kind and their considerable
use of pharmaceuticals lends them to an increased risk of ADEs (Bourgeois et al., 2010;
Nickel et al., 2013). This population also tends to have multiple comorbidities, such as
congestive heart failure, diabetes, and cancer, live in rural areas, and have a higher
severity of illness; all of which increase the risk of ADEs (Salvi et al., 2012; Sikdar et al.,
2012). Steinman, Hanlon, Sloane, Boscardin & Schmader (2011) have shown that
“geriatric conditions” alone, such as disability in at least one activity of daily living, mild
or moderate dementia, incontinence, a recent fall, needing assistance with ambulation,
malnourishment, depression, and prolonged bed rest, do not increase the risk of ADEs.
Other researchers believe that unnecessary or inappropriate use of medications are
the “true risk factor” for ADEs (Field, Gurwitz, Harrold, Rothschild, DeBellis, et al.,
2004; Parsons et al., 2011; Salvi et al., 2012; Stuck et al., 1994). Inappropriate or
unnecessary use of medications, such as antibiotics, cardiovascular agents, anti-diabetic
drugs, antiplatelet agents, and others, are commonly determined to be the cause of an
ADE (D S Budnitz et al., 2007; Daniel S Budnitz et al., 2005; Daniel S Budnitz,
Lovegrove, Shehab, & Richards, 2011; Cahir, Bennett, Teljeur, & Fahey, 2014; Capuano
et al., 2009; Y.-C. Chen et al., 2014; Elixhauser & Owens, 2007; Field, Gurwitz, Harrold,
Rothschild, DeBellis, et al., 2004; Olivier et al., 2009; Parsons et al., 2011; Shehab, Patel,
Srinivasan, & Budnitz, 2008; Sikdar et al., 2012; Tangiisuran, Davies, Wright, &
Rajkumar, 2012; Weiss et al., 2013). Most of these ADEs are preventable during the
prescribing process (D. Bates et al., 1995). As the number of drug classes taken by a
single individual increases, there is an increased risk of ADEs due to harmful drug
interactions (Cahir et al., 2014; Hines & Murphy, 2011).
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The lack of communication and coordination between healthcare providers is also
a commonly cited risk factor of ADEs (Boockvar et al., 2009; Parsons et al., 2011).
Green, Hawley, & Rask (2007) found that the number of prescribing physicians was an
independent risk factor for self-reported ADEs. Concurrent prescribing by multiple
providers is a common practice among older adults and has been associated with higher
rates of hospital admission (Jena, Goldman, Weaver, & Karaca-Mandic, 2014). The final
few potential causes of ADEs include: non-adherence to medication regimens (Cahir et
al., 2014; Malhotra et al., 2001; Parsons et al., 2011; Salvi et al., 2012), and the lack of
drug knowledge dissemination (Leape et al., 1995).
With the high risk, multiple potential causes, and high cost of ADEs in the older
patient population, it is essential to ensure effective prescribing habits are followed and
ADEs are prevented (Willlams, 2002). Fortunately, the most preventable adverse events
that have severe complications are more identifiable than less severe adverse events (D
W Bates et al., 1994). Howard et al. (2007) used Reason's (1990) “Swiss cheese model”
to demonstrate how system failures, active breakdowns, and proximal causes lead to
many ADE hospitalization in ambulatory care patients.
ADE Prevention
Several methods have been proposed and utilized by healthcare professionals to
detect and reduce ADEs, including explicit criteria for potentially inappropriate
prescriptions for adults 65 years and older, incorporating pharmacist input into all aspects
of medication management, improving communication between providers, conducting
retrospective reviews, using computerized information systems and alerts, and educating
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patients on the benefits of medication compliance and risks of polypharmacy (Garcia,
2006).
Many explicit criteria have been developed to improve medication management
among the older patient population, including Beers criteria, Screening Tool of Older
Persons’ Prescriptions (STOPP) and Screening Tool to Alert doctors to Right indicated
Treatment (START) criteria, the Research on Adverse Drug Events and Reports
(RADAR) Project, and the National Coordinating Council for Medication Error
Reporting and Prevention (NCC MERP) (Garcia, 2006; “National Coordinating Council
for Medication Error Reporting and Prevention,” 2014a; Pretorius, Gataric, Swedlund, &
Miller, 2013). Beers criteria was initially created using the Delphi method for consensus
on defining inappropriate medication use in nursing homes (Beers et al., 1991). This
criteria was updated in 2003 to be applicable to all adults 65 years and older, regardless
of living conditions (Fick et al., 2003). However, some studies have found that Beers
criteria, though widely used, may not be enough to reduce the risk of ADEs (Page 2nd &
Ruscin, 2006). STOPP and START were also created using the Delphi consensus
technique, which resulted in 65 clinically significant criteria for STOPP and 22 evidencebased prescribing indicators for START (Gallagher, Ryan, Byrne, Kennedy, &
O’Mahony, 2008). The RADAR Project, funded by the National Heart, Lung, and Blood
Institute, the National Cancer Institute, the American Cancer Society, and the Department
of Veterans Affairs, supplements other national surveillance projects by identifying,
evaluating, and disseminating information that describe serious adverse drug reactions to
physicians (Bennett et al., 2005). The NCC MERP is an independent body comprised of
27 national organizations that strive to increase the safe use of medications to increase the
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awareness of medication errors through reporting, understanding, and preventing
(“National Coordinating Council for Medication Error Reporting and Prevention,”
2014a). Other criteria created for a similar purpose include: the Improved Prescribing in
the Elderly Tool (IPET), the Prescribing Appropriateness Index (PAI), Zhan’s Criteria,
the French Consensus Panel List, the Australian Prescribing Indicators Tool, the
Norwegian General Practice (NORGEP) Criteria, the Medication Appropriateness Index
(MAI), and the Assessment of Underutilization of Medication (AOU) Tool (O’Connor,
Gallagher, & O’Mahony, 2012).
The second method utilized to detect and reduce ADEs is a provider-oriented and
provider-led process. Involving all providers in shared decision making and
individualizing prescribing decisions to patient specific characteristics, such as age, race,
comorbidities, etc. has been shown to reduce ADEs (Pretorius et al., 2013). To ensure
this method is effective, it is encouraged the pharmacist-led medication reviews occur
(Cresswell et al., 2007; Gallagher, Barry, & O’Mahony, 2007; Garcia, 2006; Sorensen et
al., 2004), educational outreach interventions are available to enhance professional
behaviors (Cresswell et al., 2007), and providers communicate and coordinate medication
management and care provision (Green et al., 2007). With 38.1% of Medicare Part D
beneficiaries utilizing multiple pharmacies and 43% of older Americans being prescribed
medications by more than one physician, medication reconciliation and communication
among prescribers is essential to preventing medication errors (Barnsteiner, 2005;
International Communications Research for the American Society of Health-System
Pharmacists, 2001; Z Marcum, Driessen, Thorpe, Gellad, & Donohue, 2014). The
inclusion of pharmacists in all stages of medication delivery has also been stressed by
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several studies (Anderson, 2003; Fuji & Galt, 2008; Garcia, 2006). In fact, the Brigham
and Women’s Hospital decreased ADE rates in the intensive care unit by 67% by
including pharmacists in patient rounds (Leape et al., 1999).
Bates & Gawande (2003) state three methods by which HIT functions, such as
ADE alert systems, computer decision support systems (CDSS), and e-prescribing, can
reduce errors: by preventing errors and adverse events, facilitating rapid response after an
adverse event, and tracking and providing feedback about adverse events. Hwang, Lee,
Koo, & Kim (2008) found that most ADEs and nearly all severe ADEs were identifiable,
though ADE hospitalizations were not included in the definition of severe ADEs. D W
Bates, Boyle, Vander Vliet, Schneider, & Leape (1995) also found that computerized
physician order entry systems could prevent the majority of medication errors and ADEs.
Computerized systems allow for increased access to patient and drug information at the
point of care and have the capability for CDSS alerts that incorporate explicit criteria,
such as those described previously (Beuscart et al., 2009; Garcia, 2006; Leape et al.,
1995; Nwulu, Nirantharakumar, Odesanya, McDowell, & Coleman, 2013; Pham &
Dickman, 2007). CDSS and e-prescribing provide methods to prevent medication errors
and ADEs through process simplification, system linkages, and patient-specific alert
systems (D W Bates et al., 2001; Bell & Friedman, 2005). A single hospital was able to
detect 26% of medication errors and prevent associated ADEs that could have resulted in
1,226 days of hospitalization and $1.4 million (Anderson, Jay, Anderson, & Hunt, 2002).
The Veterans Administration hospitals used HIT to reduce incorrectly administered
medications from 1 in 20 to less than 1 in 100,000 ambulatory care prescriptions
(President’s Information Technology Advisory Committee, 2004). Additionally,
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INTERCheck, a computerized prescription support system developed in Northern Italy to
aid in prescription management for elderly patients with multiple comorbidities, was
associated with a decrease in potentially inappropriate medication prescriptions and
potential drug-drug interactions in an Italian acute geriatric ward (Ghibelli et al., 2013).
In several instances, these systems have also decreased pharmacy department costs, drug
costs, severity-adjusted mortality rates, and non-missed-dose medication errors (D W
Bates et al., 1999; Piontek et al., 2010).
On the other hand, although e-prescribing software products have been said to be
cost-effective and an added value for all practice sizes (Corley, 2003; Honigman et al.,
2001), ADE detection algorithms are far from perfect. Continued enhancement for
consideration of clinical priorities will increase their utility (Forster, Jennings, Chow,
Leeder, & van Walraven, 2012; Rask et al., 2005).
Computerized information systems can also be utilized retroactively. For
example, a web tool called “ADE Scorecard” screens past hospitalizations extracted from
an EHR and allows physicians to see ADE statistics within their department, useful rules,
and review ADE cases through a comprehensive interface with de-identified records
(Chazard, Băceanu, Ferret, & Ficheur, 2011). As stated previously, computerized systems
only provide a tool for detecting and reducing ADEs (Anderson, 2003). The human
factors perspective views errors in two ways: the person approach, which focuses on
individuals, and the system approach, which concentrates on the conditions surrounding
the individuals (Reason, 2000). Smetzer (1998) describes how three nurses were charged
with negligent homicide for medication errors that resulted in the death of a newborn.
While this incident did not involve a computerized system, it illustrates how
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approximately 50 system failures, such as staff inexperience, poor documentation,
unclear manufacturer labeling, and no staff education before dispensing nonformulary
drugs, resulted in a devastating tragedy. Without process change and a systems
perspective, computerized information systems could result in similar unintended
negative consequences (Anderson et al., 2002; Greene, 2006).
These major strategies are generally complemented with patient education to
encourage symptom reports (Garcia, 2006) or retroactive strategies, such as root cause
analysis, failure mode effect and criticality analysis, and human factor engineering, to
determine human, organization, and cognitive factors that influence the rate of ADEs
(Beuscart et al., 2009; Gertler, Coralic, López, Stein, & Sarkar, 2014; Schneider, 2002;
Williams & Talley, 1994). The use of multiple strategies, such as an IT intervention in
conjunction with inter-professional communication, and a systems approach to reducing
ADEs have been encouraged in the literature by many (Field, Gurwitz, Harrold,
Rothschild, Debellis, et al., 2004; Lainer, Mann, & Sönnichsen, 2013; Reason, 2000;
Salvi et al., 2012; Schaubhut & Jones, 2000; Silverman et al., 2003).
Intersection of Patient Safety and Health Information Technology
Using the ten rules provided by the IOM’s Crossing the Quality Chasm report as a
backbone, Kilbridge (2002) describes the potential of health information technology
(HIT) to aid in meeting quality standards with illustrative case study examples. The four
main principles of healthcare that are described include patient empowerment, reliability
and safety, care relationships beyond the encounter, and public accountability for quality.
Technologies with the ability to aid in the improvement of healthcare quality include
personal health records, electronic medical records, pre-visit intakes, health information
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exchange, population management tools, electronic messaging, online scheduling,
computer-assisted telephone triage and assistance, and publicly available provider
performance data.
HIT offers the potential to reduce risk by assisting in decisions, providing
feedback on performance and steamlining care (David W Bates & Gawande, 2003;
Myers & Shannon, 2012). Key features offered by HIT include improved
communication, especially between clinicians (David W Bates & Gawande, 2003;
Huckvale et al., 2010; Rao, Brammer, McKethan, & Buntin, 2012); providing access to
information at the point-of-care (David W Bates & Gawande, 2003; Huckvale et al.,
2010; Rao et al., 2012); combating medication errors (David W Bates & Gawande, 2003;
Huckvale et al., 2010; van Doormaal et al., 2009); support in evidence-based decision
making (David W Bates & Gawande, 2003; Huckvale et al., 2010); and improved
medication safety through rapid response and tracking of adverse events (David W Bates
& Gawande, 2003; Huckvale et al., 2010; Jha, Kuperman, Rittenberg, Teich, & Bates,
2001).
A systematic review conducted by Chaudhry et al. (2006) on the impact of HIT
on quality, efficiency, and costs of health care had several promising findings. The
review found improvements in quality through the use of HIT to be attributable to an
increase in adherence to guidelines, enhanced disease surveillance, and decrease in
medication errors. Efficiency was also improved through a decrease in the utilization of
care. They also reported only limited data on cost savings, time utilization,
interoperability, and consumer use of HIT. A major limitation to this review was the
generalizability of these findings; as many studies were conducted in single organizations
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or healthcare systems. Another review conducted by Buntin, Burke, Hoaglin, &
Blumenthal (2011) has found mostly positive and mixed-positive improvements in access
to care, preventive care, care processes, patient satisfaction, patient safety, provider
satisfaction, effectiveness of care, and efficiency of care. However, other reviews have
stated that more robust evaluations of HITs are necessary to determine the true impact on
quality and safety (Black et al., 2011; Parente & McCullough, 2009).
While there are many types of HITs available to aid in the quality and patient
safety initiatives of the U.S. healthcare system, computerized provider order entry
(CPOE), health information exchange (HIE), and clinical decision support systems
(CDSS) have the greatest potential for patient safety (J. C. H. Chen, Dolan, & Lin, 2004;
Kaelber & Bates, 2007; Lilja & Egebart, 2011; McGregor et al., 2006). CDSSs are
designed to aid healthcare provider clinical decision making; software algorithms provide
patient-specific recommendations to practitioners. These systems have shown improved
practitioner performance and adherence to evidence-based practice guidelines (Ahmed,
Tamblyn, & Winslade, 2014; A. X. Garg et al., 2005; Roy et al., 2009; Toth-Pal, Wårdh,
Strender, & Nilsson, 2008). CPOE systems, which can be implemented with a CDSS
feature, are electronic applications that allow for direct entry of orders for laboratory
tests, procedures, radiology imaging, and medications (Hook & Cusack, 2008). CPOE
has also been shown to have significant improvements in patient safety initiatives,
including medication safety and reduction in adverse drug events (Devine et al., 2010;
Eslami, Abu-Hanna, & de Keizer, 2007; A. X. Garg et al., 2005; Shamliyan, Duval, Du,
& Kane, 2008; Wolfstadt et al., 2008). Lastly, HIE provides healthcare providers secure,
electronic access to a patient’s medical information. With a complete medical history
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available at the point-of-care, HIE is expected to reduce medication errors, improve
diagnoses, decrease duplicate testing, in addition to other benefits (Frisse et al., 2012;
Jones, Friedburg, & Schneider, 2011; Office of the National Coordinator for Health
Information Technology, n.d.-b).
Electronic Prescribing (e-prescribing) in the U.S.
To ensure that HIE is possible and a societal benefit can be realized, one of the
key components of the Office of the National Coordinator for Health Information
Technology (ONC) strategic framework included interoperability or the ability of
healthcare systems to work together (Brailer, 2005; Office of the National Coordinator
for Health Information Technology, n.d.-a). Interoperability benefits are spread across
many different stakeholders (Brailer, 2005). Specifically, improvements can be seen in
medication, laboratory, radiology, and public health information processing;
communication among providers; and communication between patients and providers
(Kaelber & Bates, 2007).
Federal Legislation & Incentive Programs
In an effort to accelerate adoption of HITs in the U.S., federal legislation and
incentive programs have been established. The Medicare Prescription Drug,
Improvement, and Modernization Act (MMA) of 2003 included a provision to increase
the adoption of electronic prescribing (e-prescribing). The potential to improve accuracy
and efficiency of medication use in Medicare beneficiaries was a leading factor in the
MMA requirement for Part D plans to support a voluntary e-prescribing program (Bell &
Friedman, 2005). Additionally, the National Committee on Vital and Health Statistics
was to aid in the initial development standards for e-prescribing.
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In April 2004, former President Bush set a goal for the majority of Americans to
use electronic health records (EHRs) by the year 2014. Additionally, the President’s
Information Technology Advisory Committee (PITAC) published a report titled
Revolutionizing Health Care Through Information Technology. This report contained a
framework for a healthcare information infrastructure, which centered around 4 elements:
1) EHRs for all Americans; 2) computer-assisted CDSS to enhance evidence-based
decision making at the point-of-care; 3) CPOE; and 4) electronic HIE that is secure,
private and interoperable (President’s Information Technology Advisory Committee,
2004). In 2005, the Centers for Medicare and Medicaid Services (CMS) published a final
rule on standards for providers and pharmacies using e-prescribing.
In November 2008, the CMS introduced the e-prescribing (eRx) Incentive
Program, as part of the Medicare Improvements for Patients and Providers Act of 2008
(MIPPA). This program offered incentives to physicians and other eligible professionals
who met certain eligibility requirements. Beginning January 2009, CMS began offering
e-prescribe payment incentives to eligible providers of up to 2% of their Medicare Part B
charges for services. In 2012, a total of $334,331,216 in eRx Incentive Program payments
were made to 227,447 eligible professionals and 55,015 practices (Centers for Medicare
and Medicaid Services, 2014a). Between the years of 2010 and 2012, a total of
$891,275,859 were paid to eligible professionals and practices through the eRx Incentive
Program (Centers for Medicare and Medicaid Services, 2014a).
President Obama renewed the commitment to EHRs set by former President Bush
by allocating funds for the CMS EHR Incentive Program through the Health Information
Technology for Economic and Clinical Health (HITECH) Act in the American Recovery
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and Reinvestment Act of 2009 (ARRA). The CMS EHR Incentive Program is guided by
“Meaningful Use” criteria, a program that parallels the eRx Incentive Program. Several
objectives of the Meaningful Use criteria are pertinent to medication management: the
ability to generate and transmit permissible prescriptions electronically and use CPOE for
medication orders directly entered by any licensed healthcare professional who can enter
orders into the medical record per state, local, and professional guidelines (Blumenthal &
Tavenner, 2010). Several other guidelines, such as implementing drug-drug and drugallergy interaction checks, maintaining active medication lists, maintaining active
medication allergy lists, and implementing drug-formulary checks, were incorporated
into clinical decision support and summary of care document measures and are no longer
separate objectives in Stage 2 Meaningful Use criteria (Centers for Medicare and
Medicaid Services, 2012). The CMS EHR Incentive Program to-date has awarded
$21,612,234,517 to eligible Medicare and Medicaid professionals and hospitals (Centers
for Medicare and Medicaid Services, 2014b).
The HITECH Act also established the ONC to coordinate national efforts on
health information technology. A key component to the strategic framework of the ONC
was interoperability, which allows for the providers to communicate with one another
(Kuperman, 2011). The final big portion of the HITECH Act was the State Health
Information Exchange Cooperative Agreement Program , which awarded $547,703,438
to 56 states and eligible territories through the ONC (Office of the National Coordinator
for Health Information Technology, 2014c). This program was created to assist in
building the capacity for exchanging health information at the state-, regional-, and
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national- level. This program included, but was not limited to, the implementation of
infrastructure for e-prescribing.
Adoption of HITs and e-Prescribing
It is important to note the distinction between HIT and e-prescribing prior to
discussing the adoption rates of each. HIT, as used in this study, refers to a broad concept
that can include technologies with many different functions such as EHRs or personal
health records. E-prescribing, on the other hand, refers to a specific function or
subfunction that can be utilized in a standalone system, as part of a CPOE system, or can
be incorporated into an EHR system.
Despite the economic incentives provided by the federal government through the
programs documented in the preceding section, the adoption of HIT systems has
historically been low (Karsh, Weinger, Abbott, & Wears, 2010). In 2006, the use of HIT
features ranged between 10-50% (Brooks, Menachemi, Burke, & Clawson, 2005; Figge,
2009; Furukawa, Raghu, Spaulding, & Vinze, 2008; Poon et al., 2006). However,
significant differences in the adoption of various features have emerged and currently
hospitals have shown greater adoption rates than physician practices (Furukawa et al.,
2008; Pallin, Sullivan, Kaushal, & Camargo, 2010). The least adopted electronic
capabilities among physicians include patient engagement, structured lab results, and
immunization registry reporting (Office of the National Coordinator for Health
Information Technology, 2014b).
Despite low rates of adoption of most HITs, the rate of medication-related
computerized capabilities has increased dramatically among inpatient and ambulatory
care physicians during the past decade. These significant increases in adoption rates may
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be due in part to the early focus on e-prescribing and continued federal incentives, as
discussed previously. In 2005, Massachusetts reported 38% of their emergency
departments had medication ordering capabilities (Pallin et al., 2010). Between the years
of 2009-2013 there was a significant increase in use of CPOE for medication, drug
interaction checks, and CDSS (J. King, Patel, & Furukawa, 2012). Furthermore, the rates
of e-prescribing have nearly doubled from 33% to 73% between 2009-2012 (J. King et
al., 2012). Others report the percentage of physicians e-prescribing via an EHR increased
from less than 10% in 2008 to over 65% in 2013 (Hufstader, Swain, & Furukawa, 2012;
Office of the National Coordinator for Health Information Technology, 2014a;
Surescripts, 2012).
Barriers to e-Prescribing
E-prescribing, like many other HIT functions, was initially slow to be adopted due
to financial barriers, legal barriers, lack of standards, and cultural barriers (David W
Bates & Gawande, 2003; Buntin et al., 2011; J. C. H. Chen et al., 2004; Furukawa et al.,
2008). Other initial obstacles to e-prescribing adoption included the financial cost of
implementation, which ranges from $500-$2,500 per year for a stand-alone system to
$25,000-$45,000 per physician for a comprehensive EHR system (Bell & Friedman,
2005; Figge, 2009; Furukawa et al., 2008; Jariwala, Holmes, Banahan 3rd, & McCaffrey
3rd, 2013; Lundy, Anderson, & Valentine, 2009); incompatibility between different
vendor systems (Bell & Friedman, 2005) (Balfour 3rd et al., 2009; Bell & Friedman,
2005); confusion about functionality (Bell & Friedman, 2005); limited connectivity
(Lundy et al., 2009); resistance to change (Jariwala et al., 2013; Lundy et al., 2009); and
the prohibition on e-prescribing for controlled substances (Lundy et al., 2009).
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The implementation of e-prescribing systems is not a simple “plug and play”
system; it requires not just the technology itself (Karsh et al., 2010), but also the
resources to ensure that system is tailored to the needs of the organization (Damberg et
al., 2009; Nanji et al., 2011). The true value of the technology is how it is utilized by the
individuals and organizations (Prince & Herrin, 2007). Several organizational changes
need to be made prior to the implementation of any new technology (Menachemi, Burke,
& Brooks, 2004). These changes include: workflow redesign that includes rethinking
employee roles and responsibilities (Crosson et al., 2011; Ford, Huerta, Thompson, &
Patry, 2011), a strategic importance placed on information technology (Menachemi et al.,
2004), a commitment from staff and upper management (Damberg et al., 2009; Prince &
Herrin, 2007; Shah et al., 2006), and the continued involvement and enthusiasm of
organizational leadership (Menachemi et al., 2004). The implementation of any
technology requires persistence. If organization and “human” factor changes are not
addressed, this could lead to an increase in medication errors (Damberg et al., 2009;
Nanji et al., 2011).
Benefits & Unintended Consequences of e-Prescribing
From a communication and safety standpoint, e-prescribing results in
prescriptions that are clean and free of ambiguities (Figge, 2009), it improves patient
safety and eliminates errors (Figge, 2009), and decreases the number of emergency
department visits and medication-related hospitalizations (Weingart et al., 2009).
Providers also report patient safety benefits, though they have not perceived the enhanced
benefits that were expected (Wang et al., 2009). Providers are able to make better
medication choices, without a reduction in the time spent with patients, which has
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resulted in a decrease in medication spending for organizations and states (Fischer et al.,
2008; Weingart et al., 2009; Westbrook, Li, Georgiou, Paoloni, & Cullen, 2013). A
further discussion on the potential of e-prescribing to decrease adverse drug events is
discussed further in the adverse drug event section on page 29.
Though the benefits of e-prescribing are widespread in the literature, unintended
consequences have also been cited. One of the stated benefits of CDSS, a feature
included in many CPOE systems for medications, is that it provides alerts for
inappropriate use, drug-drug interactions, drug-allergy interactions and much more.
However, over-alerting has led to a phenomenon called “alert fatigue,” where providers
have decreased sensitivity to alerts leading to overrides due to the unspecific nature of the
alerts (Ammenwerth, Hackl, Riedmann, & Jung, 2011; Beuscart et al., 2009).
Technology-induced errors, discrepancies between structured and free-text fields, and
missing or erroneous data which results in poor decisions are all additional unintended
consequences of HIT (Borycki, 2013; Carvalho, Borycki, & Kushniruk, 2009; Palchuk et
al., 2010; Sittig & Singh, 2011). Many of these errors will diminish as software products
are engineered with safe user interfaces (Magrabi, Ong, Runciman, & Coiera, 2011).
These updates should result in decreased confusion of medicine names, poor design of
screens, and order entry errors (Ash et al., 2007; Cheung et al., 2014). Organizational
process changes that are required for the successful implementation of any technology,
such as workflow redesign and interpersonal relations, will require continuous
monitoring, as will reimplementation of systems for upgrades and replacement systems
(Ash et al., 2007).
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As policy initiatives and payment restructuring continue, the electronic exchange
of health information and the implementation of e-prescribing will continue to accelerate
(Furukawa, Patel, Charles, Swain, & Mostashari, 2013). As the adoption of e-prescribing
rises, there is an increasing need to study the impact these technologies are having on the
patient safety outcomes, such as medication errors and adverse drug events, in our
healthcare system.
Previous Research
The literature on the impact of HITs, including CPOE, CDSS, and e-prescribing
on ADEs is sparse; Table 2.2 provides a comparison of these studies. Studies that 1) only
examined the ADE detection abilities of HITs; 2) were computer simulations; 3) only
examined the impact on possible/potential, not actual, ADEs; and 4) were systematic
reviews were excluded from the comparison. Of the studies meeting the search criteria, 5
observed a significant reduction in ADEs after the implementation of a HIT, 1 detected a
reduction in harmful ADEs but no difference in all ADEs, and 8 observed no statistically
significant difference due to HIT. Studies examining the impact of HIT on ADEs were
typically conducted within institutions and lacked external validity. Therefore, the
proposed study for this dissertation innovates by providing a population-based approach
to examining the association between HIT and ADEs.
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Table 2.2 Comparison of studies examining the impact of health information technology on adverse drug events
Author(s)
Years of
Study Design HIT used
Setting
Outcome of
Limitations
Major Findings
Study
Interest
regarding ADEs
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(D W Bates
et al., 1998)

1993-1995

Pre/post
analysis

CPOE and
the
combination
of CPOE
plus a team
intervention

Brigham and
Women’s
tertiary care
hospital in
Boston, MA

Nonintercepted Not generalizable
serious
medication
errors

(D W Bates
et al., 1999)

1992-1997

Time series
analysis

CPOE with
CDSS

Three
medical units
in Brigham
and Women’s
tertiary care
hospital in
Boston, MA

Medication
errors
(including
adverse drug
events)

(Colpaert et
al., 2006)

2004

Controlled
crosssectional trial

CPOE

Intensive care
unit of
tertiary care
university
Hospital

Difference in
incidence and
severity of
medication
prescription
errors in the
computerized
versus the

Not generalizable
Detection
methodology
better for
detecting errors in
ordering than
medication
administration
Not generalizable

Preventable ADEs
declined by 17%
(4.69 to 3.88 per
1000 patient-days;
p=.37)
Nonintercepted
potential ADEs
declined 84%
(5.99 to 0.98 per
1000 patient-days;
p=0.002)
Preventable ADEs
highest in period 1
(5.7 events per
1000 patient-days)
No significant
change in ADEs

Reduction of
ADEs (2 v. 12;
p<0.01)

2002-2006

Pre/post
analysis

CPOE with
limited
CDSS

(Evans et
al., 1994)

1989-1992

Pre/post
analysis

(Evans et
al., 1995)

1994-1995

Pre/post
analysis

Computerize
d alerts of
drug
allergies,
standardized
antibiotic
administrati
on rates, and
timely
physician
notification
of all ADEs
CDSS for
treatment of
infections

(Evans et

1992-1995

Pre/post
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(Devine et
al., 2010)

CDSS for

paper-based
unit
Community- Occurrence of
based,
errors; types
multispecialty and severity of
health system errors

Homegrown
system
Not generalizable

Reduction in
preventable ADEs
was not
statistically
significant,
perhaps due to few
errors in this
category
Reduction in type
B ADEs (56 in
baseline vs. 8 and
18 in subsequent
study periods;
p<0.002)

LDS Hospital
in Salt Lake
City, UT

Number of
Type B
(allergic or
idiosyncratic
reactions) and
severe ADEs

Unable to
determine impact
of each individual
intervention
Homegrown
system
Not generalizable

Shock/
Trauma/
Respiratory
Intensive
Care Unit at
LDS Hospital
in Salt Lake
City, UT
LDS Hospital

Number of
antibiotic
ADEs

Not generalizable
Homegrown
system

Reduction in
number of
antibiotic ADEs
was no statistically
significant (2.4%
v. 0.9%; p=0.164)

Number of

Not generalizable

Reduction in

al., 1998)

analysis

treatment of
infections

in Salt Lake
City, UT

adverse events
caused by
antiinfective
agents

Homegrown
system

2 hospitalbased and 2
communitybased
primary care
practices
affiliated with
academic
medical
center in
Boston, MA
2 large longterm care
facilities in
CT and
Ontario,
Canada

Number of
medication
errors,
potential
ADEs, and
preventable
ADEs

Not generalizable
No power to
detect modest
differences
between
computerized and
handwritten
Physicians not
blinded to study

Number of
ADEs

Not generalizable
Homegrown
system
Potential
contamination by
crossover of
physicians

Children’s
Hospital of
Eastern
Ontario,
tertiary care
pediatric

Rate ratios for
medication
errors,
potential
ADEs, and
ADEs

Not generalizable
Medication errors
and ADEs
detected using
passive reporting
system at institute

1999-2000

Prospective
cohort study

eprescribing

(Gurwitz et
al., 2008)

Unclear

Clusterrandomized
controlled
trial

CPOE with
and without
CDSS

(W. J. King,
Paice,
Rangrej,
Forestell, &
Swartz,
2003)

1993-1997

Retrospective
cohort study

CPOE

31

(Gandhi et
al., 2005)

adverse events
caused by
antiinfective
agents (4 v. 28;
p<0.02)
Not enough
preventable ADEs
were observed
during study
period to
determine change

No statistically
significant
reduction of ADEs
or preventable
ADEs (adjusted
rate ratios: 1.06
(CI: 0.92-1.23) and
1.02 (CI:0.811.30), respectively)
No statistically
significant
decrease in ADEs
(ratio of rate ratios:
1.30; CI: 0.473.52)
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(Mullett,
1998-1999
Evans,
Christenson,
& Dean,
2001)

Pre/post
analysis

(Pestotnik,
Classen,
Evans, &
Burke,
1996)

1988-1994

Observational

(Steele et
al., 2005)

2002-2003

Pre/post
analysis

teaching
hospital
affiliated with
University of
Ottawa,
Canada
CDSS for all Pediatric
antiinfective intensive care
orders
unit at
Primary
Children’s
Medical
Center at the
University of
Utah
Antibiotic
Community
management teaching
program
hospital in
embedded in Salt Lake
CDSS
City, UT

CPOE with
CDSS

Denver
Health
outpatient
primary care
clinics

Numbers of
ADEs

Not generalizable
Only conducted
on pediatric
population
Homegrown
system

No change in
ADEs attributable
to antiinfectives

Rates of
ADEs, patterns
of
antimicrobial
resistance,
mortality, and
length of
hospital stay,
financial and
use outcomes
ADEs

Observational
study (no baseline
data)
Not generalizable

Antibioticassociated adverse
drug events
decreased by 30%

Only focused on
specific druglaboratory
interactions
Not generalizable

No statistically
significant
difference in ADEs
defined by Naranjo
scoring (10.3% v.
4.3%; p=0.23)

(Upperman
et al., 2005)

2002-2003

(van
2005-2008
Doormaal et
al., 2009)

33

Pre/post
analysis

CPOE

Children’s
Hospital of
Pittsburgh

Ratio of rates
per 1000 doses
dispensed for
ADEs

Not generalizable
Extra emphasis on
ADE reporting
during process

Interrupted
time-series

CPOE with
CDSS

University
Medical
Center
Groningen in
Tilburg and
Waalwijk,
Netherlands

Percentage of
patients with
one or more
preventable
ADEs

Not generalizable

Reduction in
harmful ADEs
(0.05 v. 0.03;
p=0.05)
No statistically
significant
different in all
ADE types (0.3 v.
0.37; p=.3)
Direct effect on
preventable ADEs
was not
demonstrated

Theoretical Framework
The use of theory is an essential, but underutilized element of research studies
(Colquhoun et al., 2013). This dissertation research will be grounded in a combination of
several theories including: Berwick's (2003) application of Roger’s classic diffusion of
innovation theory to the healthcare industry and Ancker, Kern, Abramson, & Kaushal's
(2012) Triangle Model adaptation of Donabedian's (1988) structure-process-outcome
model to evaluate the impact of health information technology on quality and safety.
Each component of the new theoretical framework, which expands upon the Triangle
Model, is illustrated in Figure 2.2 and described below.
While the Triangle Model lends itself to evaluating the impact of HIT within an
organization, this new theoretical framework provides a systems’ approach on describing
the impact of HIT on healthcare outcomes. The new theoretical framework also provides
a detailed explanation of each major element of the Triangle Model, using Berwick
(2003) and Rogers (1995). The four structural elements: technology, provider,
organization, and patient population from the Triangle Model are used as the backbone of
the framework. The three processes are: the technology usage by providers; the
implementation of technology by the organization; and the organizational factors that
impact providers. The outcomes on the healthcare system (referred to as consequences in
the new model) are impacted by each structure and process within the system.
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Figure 2.2 Theoretical Framework

Healthcare System
Innovation /
Technology

Organization-Technology
Processes

Provider-Technology
Processes
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Infrastructure

Organization-Provider
Processes

Consequences /
Outcomes

Adopter /
Provider

Technology
According to Rogers (1995), five key features--relative advantage, compatibility,
complexity, trialability, and observability--are the most influential in determining the
perception of a new technology or innovation. The first feature, relative advantage or
perceived benefit, is one of the most powerful properties of innovation adoption. The
majority of individuals adopt innovations when they are easy to understand and the
benefits outweigh the risks. The second feature, compatibility, refers to the level at which
the innovation aligns with the values, beliefs, and needs of the individual. For example,
EHRs are typically designed to meet the needs of large urban hospitals. The same system
would not be compatible with the values and needs of a small rural hospital, which cares
for an entirely different patient population. The complexity or adaptability of an
innovation also impacts adoption. If an innovation cannot be simplified or modified for
specific use, the rate of diffusion is diminished. Lastly, having the ability to test
(trialability) and see the innovation used by others (observability) can be used to predict
adoption. These five perceptions of innovations can be utilized to determine the whether
an innovation or technology will be adopted. When adoption curves, typically S-shaped,
reach between 15% and 20% the innovation gains momentum and is adopted at an
increasing rate.
Adopter / Provider
Specific characteristics of the adopter, or the healthcare provider, are also
associated with the rate of spread of a technology. Using the classic statistical bell curve,
adopters are split into 5 different groups: innovators, early adopters, early majority, late
majority, and laggards. The fastest adopting group, the innovators, occupies the first
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2.5% of the bell curve. These individuals tend to be willing to take risks, have the
financial means to take the risk, and are in close contact with scientific research and other
innovators (Rogers, 1995). In healthcare, physician innovators tend to be thought of as
“mavericks or may appear to be heavily invested personally in a specialized topic”
(Berwick, 2003). The next group, the early adopters, is the next 13.5% of the bell curve.
They are similar to innovators, but they are more discrete in their choice of adoptions and
are seen as opinion leaders among their peers (Rogers, 1995). Within the healthcare
industry, these adopters are generally elected leaders or clinical group representatives
(Berwick, 2003). The next 34% of the bell curve is occupied by the early majority, who
are in average social status, are risk averse, and look to others to determine their adoption
choices (Rogers, 1995). Physicians in the early majority tend to adopt innovations based
on their immediate needs (Berwick, 2003). The late majority, the second 34% of the bell
curve, is highly skeptical and adopts long after their peers (Rogers, 1995). The final
groups, the laggards, are the final 16% of the adoption curve. They are typically
“traditionalists” and only make changes when absolutely necessary (Rogers, 1995).
Organization / Health System
The final set of factors that influence the rate of adoption of an innovation are
contextual or managerial factors of an organization, such as mission, resources, and
policies. The culture within an organization determines whether providers are more or
less likely to adopt an innovation or technology. If an organization provides praise and
encourages innovation, providers will be more likely to try novel ideas, while
organizations that are traditionalists and discourage innovators are less likely to see
change. Rogers (1995) discusses three types of leadership styles that impact the rate of
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adoption or spread within an organization, called innovation-decisions: optional,
collective, authority. Optional innovation-decisions are made independently by
individuals, collective innovation-decisions are made via a consensus within an
organization and all members of the organization are required to follow, and authority
innovation-decisions are decisions made by a few powerful members of an organization
and impact the entire organization. The adoption of technology within a healthcare
organization is generally a collective or authority decision, depending on the size and
organizational structure. However, single- or small group- practices make optional
decisions, though they may be influenced by the norms of healthcare and the input of
other providers.
Patient
Central to the entire adoption process are patients. The patient population that a
healthcare organization serves impacts the outcomes or consequences of technological
adoption. The American population, in general, believes that HIT is an effective means of
improving the quality and safety of health care (Gaylin, Moiduddin, Mohamoud,
Lundeen, & Kelly, 2011). Studies have shown that HIT provides the means to increase
continuity of care (Gentles, Lokker, & McKibbon, 2010), improve communication with
patients (Gentles et al., 2010), and incorporate patient preferences to provide patientcentered care (Montague & Asan, 2012). While some studies show an increase in patient
satisfaction due to HIT (Nash et al., 2010; Restuccia, Cohen, Horwitt, & Shwartz, 2012;
Roham, Gabrielyan, & Archer, 2012; Vest & Miller, 2011), others show no
improvements (Rozenblum et al., 2013). To validly and appropriately compare different
organizations requires adjustment for the served patient populations. Risk adjustment
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should be considered for the variables including, but not limited to: case-mix,
comorbidities, health literacy, patient engagement, race, income, and age.
Processes
The processes established between the four main structural elements of the
Triangle Model include: provider-technology, organization-provider, and organizationtechnology (Ancker et al., 2012). Each of these processes has the potential to affect the
outcomes of the healthcare organization. The proper use of the technology by the
provider can impact whether positive expected outcomes are achieved. It is important to
measure the provider-technology processes through measures such as: usability and
actual use of features, integration into workflow, training effectiveness, and perceived
usefulness. The second process, describes the impact that organizational-level decisions
support use of the technology. This includes factors such as: implementation, user
training, resource allocation, and technical support. Proper support provided at the
organizational level strongly impacts the level of satisfaction at the provider level
(DeLone & McLean, 2003). Lastly, the policies and culture of an organization directly
impact the activities of a provider, which in turn impact the outcomes of the healthcare
system.
Consequences / Outcomes
According to Rogers (1995) consequences are the least studied element of the
diffusion of innovations model. The model classifies consequences as desirable or
undesirable; direct or indirect; and anticipated or unanticipated. The directness of the
consequences is based on whether the changes that are seen are immediate responses to
an innovation. Whether a consequence is anticipated or not depends on the whether the
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changes seen are recognized and intended. Consequences are also referred to as outcomes
in other models, such as the Triangle Model (Ancker et al., 2012).
Additional Factors
The adoption of technology and spread through society is measured over time,
which is one of the final two factors that are described through the diffusion of
innovations theory. Lastly, as the process of sharing ideas through communication
channels increases, the innovation spreads and the rate of adoption increases.
Study Design & Limitations of Previous Research
Studies in Table depict the literature available on the impact of HITs on ADEs.
Generalizability was a major limitation of every currently available study (Black et al.,
2011; Chaudhry et al., 2006). Furthermore, the majority of studies were conducted in a
hospital setting and were determining the rate of ADEs occurring within a hospital stay.
No studies were found that 1) examined the impact of HIT use in ambulatory settings on
ADE hospitalizations; or 2) provided a population-based approach to the research
question. The proposed study provides a population-based approach that aligns with one
of the three Triple Aims discussed previously, as well as examining the impact of the
ONC call for interoperability.
Of the three dimensions of health information users, as described in the 2001
report by the National Committee on Vital and Health Statistics, the population health
dimension allows for analysis of health system infrastructure (National Committee on
Vital and Health Statistics, 2001). Ecological studies are appealing in health services
research because the focus is on organizations or systems, rather than individual patients
(Saunders & Abel, 2014). The principal example of ecological studies in health services
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research is the use of ambulatory care sensitive condition admission rates as a measure of
primary care service availability and quality (Brown et al., 2001; A. Garg, Probst, Sease,
& Samuels, 2003). Previous health services researchers have also conducted county-level
analyses to determine the association between food environments and health outcomes
(Ahern, Brown, & Dukas, 2011), urban sprawl and cancer mortality (Berrigan,
Tatalovich, Pickle, Ewing, & Ballard-Barbash, 2014), and availability of pediatric
intensive care units to child death from trauma (Odetola, Miller, Davis, & Bratton, 2005).
Each of these studies was designed to allow for a systems perspective in the interpretation
of their findings. Similarly, the prevention of ADEs requires a systems perspective
(Anderson et al., 2002).
It is important to note that hospital and ambulatory patient safety are different in
the nature of errors, the patient-provider relationship; and organizational issues that each
face (Wachter, 2006). While providers in the ambulatory setting stress the importance of
communication and medication adherence in their offices, hospitals do not have intimate
relationships with their patients (Wachter, 2006). Additionally, hospitals are visited by
regulators, such as the Joint Commission, to ensure best practices are followed and a
minimum standard of care is offered. Ambulatory offices do not have similar
requirements (Wachter, 2006). Determining the impact of HIT on ADEs in a hospital
setting does not allow for extrapolation to ambulatory care settings.
Given these limitations of previous research, the current study will determine the
association of e-prescribing (technology) with hospitalizations for ADEs (consequence)
at a population-level. It will take a multi-county approach to determine the population
impact the adoption of technologies can have on healthcare outcomes. For the purposes
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of this study, the term ADE will refer to the combination of nonpreventable and
preventable ADEs. The distinction based on preventability of ADEs is not possible using
this dissertation research datasets. Additionally, only ADEs that result in hospitalizations
will be examined, as these events reflect the appropriateness of ambulatory prescribing
(Thürmann, 2003). Considering that the rate of adoption and use of most HITs remains
relatively low, minimum population-level impacts have been observed. Given that eprescribing can be viewed as an entry-level system compared to comprehensive HITs,
such as electronic health records (EHRs), it is hoped that the findings of this study can
provide a baseline on the impact of HIT adoption throughout the nation (Bell &
Friedman, 2005).
The specific aims and respective hypotheses of the study are:
Aim 1. Determine the relationship between the percentage of physicians in a county
using electronic prescribing (e-prescribing) and county-level rates of ADE
hospitalizations among patients 65 years and older.
Hypothesis: High proportions of e-prescribing physicians will negatively correlate
with the rates of ADE hospitalizations among patients 65 years and older.
Aim 2. Determine the association between 2008-2011 change in percentage of physicians
using electronic prescribing (e-prescribing) and change in county-level rates of ADE
hospitalizations among patients 65 years and older.
Hypothesis: As the rate of e-prescribing has increased from 2008 to 2011, the rate
of ADE hospitalizations has decreased at the county level.
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CHAPTER 3
METHODOLOGY
Purpose
The study provided a multi-state perspective on the association between eprescribing and the frequency of hospitalizations for older Americans (age 65 years and
older) due to ADEs. The specific aims and corresponding hypotheses of this study were:
Aim 1. Determine the relationship between the percentage of physicians in a county using
e-prescribing and county-level rates of ADE hospitalizations among patients 65 years and
older.
Hypothesis 1. It was hypothesized that high proportions of e-prescribing
physicians will correlate negatively with the rates of ADE hospitalizations among
patients 65 years and older.
Aim 2. Determine the association between 2008-2011 change in percentage of physicians
using e-prescribing and change in county-level rates of ADE hospitalizations among
patients 65 years and older.
Hypothesis 2. It was hypothesized that as the rate of e-prescribing had increased
from 2008 to 2011, the rate of ADE hospitalizations had decreased at the county
level.
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Institutional Review Board (IRB)
Approval from the University of South Carolina IRB was granted on July 24th,
2014. The study was categorized as “exemption status,” as de-identified secondary data
was utilized for this study.
Data Sources
This study utilized three datasets: the Healthcare Cost and Utilization Project
(HCUP) State Inpatient Databases (SID) of 6 states for the years 2008 and 2011, the
Office of the National Coordinator (ONC) Health IT Dashboard – Health IT Adoption
and Use dataset, and the Health Resources and Services Administration (HRSA) Area
Health Resource File (AHRF). The HCUP SID was used to determine the outcome of
interest, the aggregate rate of ADEs in the older adult population, based on primary
diagnosis codes. Data from the ONC Health IT Dashboard – Health IT Adoption and Use
dataset was utilized to determine the independent variable, percentage of physicians eprescribing in each county. The linked HCUP SID and ONC dataset file, were merged
with the AHRF to obtain county-level control variables.
The 2008 and 2011 HCUP SID provides a discharge record for all inpatient
hospital stays in a given state (HCUP Databases, 2014). Currently, 47 states participate in
HCUP SID; representing about 97% of all U.S. community hospital discharges. Variables
included in the dataset include, but are not limited to: diagnoses and procedures,
admission and discharge status, length of hospital stay, expected payment source, total
charges, and patient demographic characteristics. This dataset was merged with the ONC
dataset using state and county Federal Information Processing Standards (FIPS) codes.
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The ONC Health IT Dashboard is an open government project that provides the
percentage of e-prescribers that are prescribing on the Surescripts network, by county
from 2008-2013 (Office of the National Coordinator for Health Information Technology,
2014). Surescripts is the country’s largest electronic prescribing network, it is used by
approximately 95% of U.S. community pharmacies, excluding closed systems such as
Kaiser Permanente (“Surescripts,” 2014c). Medication history functionalities via the
Surescripts network allow for risk management of ADEs, drug-drug interactions, and
drug-allergy interactions (Surescripts, 2014b). The top 10 EMR vendors of certified
EMRs for healthcare professionals are utilized by 2 out of 3 healthcare professionals and
have patient medication history functionalities via the Surescripts network (Surescripts,
2014a). Of the non-dominant EMR vendors, 65.1% (450 of the 691 vendors) have
medication history functionalities enabled (Surescripts, 2014a).
Lastly, the AHRF provides an extensive county-level database drawn from more
than 50 sources, including the American Hospital Association, American Medical
Association, Centers for Medicare and Medicaid Services, the National Center for Health
Statistics, the U.S. Census Bureau, and many more (Health Resources and Services
Administration, 2014).
Study Sample
This research examined ADE hospitalization rates across 6 states, chosen because
these states include a “present on admission” (POA) indicator when providing
information to the HCUP SID (Healthcare Cost and Utilization Project, 2008). The POA
indicator indicated that the ADE occurred in the community and thus was likely to be
associated with outpatient provider prescriptions, rather than occurring during a
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hospitalization. Evidence on the reliability and usefulness of the POA indicator
demonstrates that it increases the precision of ICD-9 codes (Coffey, Milenkovic, &
Andrews, 2006; Kassed, Kowlessar, Pfunter, Parlato, & Andrews, 2011). Studied states
included Arizona, Florida, Maryland, Michigan, New Jersey, and Washington. Together,
these states include 249 counties, which formed the population of the study. Key data
elements for this study included patient demographics, principal diagnosis, and whether
the diagnosis was present on admission into the hospital (HCUP Databases, 2014). ADE
rates were calculated among patients 65 years and older. All other age groups were be
excluded from the analysis.
Study Variables
Independent Variable – Percentage of Physicians Actively E-prescribing
The independent variable for both Aims 1 and 2, percentage of physicians that
actively use e-prescribing, was obtained from the ONC Health IT Dashboard – Health IT
Adoption and Use dataset and AHRF.
Dependent Variable – Rate of ADE hospitalizations
The dependent variable for the county-level analysis for Aim 1 was the rate of
ADE hospitalizations for patients 65 years and older in the county in 2011. ADEs were
identified using Lucado, Paez, & Elixhauser's (2011) list of specific International
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) diagnosis
codes and external cause of injury codes. The list of ICD-9 codes is reprinted in Table
3.1.
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Table 3.1 International Classification of Diseases, Ninth Revision, Adverse Drug
Event Code Classification
General causes of drug-related
ICD-9 Diagnosis Codes
adverse outcomes
Hormones and synthetic substitutes 962.0, 962.1, 962.2, 962.3, 962.4, 962.5, 962.6,
962.7, 962.8, 962.9, E858.0, E932.0, E932.1,
E932.2, E932.3, E932.4, E932.5, E932.6, E932.7,
E932.8, E932.9
Analgesics, antipyretics, and
965.02, 965.09, 965.1, 965.4, 965.5, 965.61,
antirheumatics
965.69, 965.7, 965.8, 965.9, E850.1, E850.2,
E850.3, E850.4, E850.5, E850.6, E850.7, E850.8,
E850.9, E935.1, E935.1, E935.2, E935.3, E935.4,
E935.5, E935.6, E935.7, E935.8, E935.9
Agents that affect blood
964.0, 964.1, 964.2, 964.3, 964.4, 964.5, 964.6,
constituents
964.7, 964.8, 964.9, E858.2, E934.0, E934.1,
E934.2, E934.3, E934.4, E934.5, E934.6 E934.7
E934.8, E934.9
Systemic agents
963.0, 963.1, 963.2, 963.3, 963.4, 963.5, 963.8,
963.9, E858.1, E933.0, E933.1, E933.2, E933.3,
E933.4, E933.5, E933.8, E933.9
Cardiovascular drugs
972.0, 972.1, 972.2, 972.3, 972.4, 972.5, 972.6,
972.7, 972.8, 972.9, E858.3, E942.0, E942.1,
E942.2, E942.3, E942.4, E942.5, E942.6, E942.7,
E942.8, E942.9
Other and unspecified drugs and
977.0, 977.1, 977.2, 977.3, 977.4, 977.8, 977.9,
medicinal substances
E858.8, E858.9, E947.0, E947.1, E947.2, E947.3,
E947.4, E947.8, E947.9
Antibiotics
960.0, 960.1, 960.2, 960.3, 960.4, 960.5, 960.6,
960.7, 960.8, 960.9, E856, E930.0, E930.1,
E930.2, E930.3, E930.4, E930.5, E930.6, E930.7,
E930.8, E930.9
Psychotropic agents (other than
969.0, 969.1, 969.2, 969.3, 969.4, 969.5, 969.8,
hallucinogens, amphetamines, and
969.9, E853.0, E853.1, E853.2, E853.8, E853.9,
caffeine)
E854.0, E854.8, E939.0, E939.1, E939.2, E939.3,
E939.4, E939.5, E939.8, E939.9
Water, mineral, and uric acid
974.0, 974.1, 974.2, 974.3, 974.4, 974.5, 974.6,
metabolism drugs
974.7, E858.5, E944.0, E944.1, E944.2, E944.3,
E944.4, E944.5, E944.6, E944.7
Sedatives and hypnotics
967.0, 967.1, 967.2, 967.3, 967.4, 967.5, 967.6,
967.8, 967.9, E851, E852.0, E852.2, E852.8,
E852.9, E937.0, E937.1, E937.3, E937.4, E937.5,
E937.6, E937.8, E937.9
Anticonvulsants and anti-Parkinson 966.0, 966.1, 966.2, 966.3, 966.4, E855.0, E936.0,
drugs
E936.1, E936.2, E936.3, E936.4
Other anti-infectives
961.0, 961.1, 961.2, 961.3, 961.4, 961.5, 961.6,
961.7, 961.8, 961.9, E857, E931.0, E931.1,
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E931.2, E931.3, E931.4, E931.5, E931.6, E931.7,
E931.8, E931.9
Drugs effecting autonomic nervous 971.0, 971.1, 971.2, 971.3, 971.9, E855.3, E855.4,
system
E855.5, E855.6, E855.8, E855.9, E941.0, E941.1,
E941.2, E941.3, E941.9
Central nervous system depressants 968.0, 968.1, 968.2, 968.3, 968.4, 968.5, 968.6,
and anesthetics
968.7, 968.8, 968.9, E855.1, E855.2, E938.0,
E938.1, E938.2, E938.3, E938.4, E938.5, E938.6,
E938.7, E938.9
Agents acting on smooth and
975.0, 975.1, 975.2, 975.3, 975.4, 975.5, 975.6,
skeletal muscles and respiratory
975.7, E945.0, E945.1, E945.2, E945.3, E945.4,
system (e.g. muscle relaxants)
E945.5, E945.6, E945.7
Central nervous system stimulants
970.0, 970.1, 970.8, 970.9, E854.3, E940.0,
(e.g., opiate antagonists)
E940.1, E940.8, E940.9
Agents effecting the gastrointestinal 973.0, 973.1, 973.2, 973.3, 973.4, 973.5, 973.6,
system (e.g., cathartics)
973.8, E858.4, E943.0, E943.1, E943.2, E943.3,
E943.4, E943.5, E943.6, E943.8, E943.9
Agents effect skin, mucous
976.0, 976.1, 976.2, 976.3, 976.4, 976.5, 976.6,
membranes, eye, ENT, and dental
976.7, 976.8, 976.9, E858.7, E946.0, E946.1,
E946.2, E946.3, E946.4, E946.5, E946.6, E946.7,
E946.8, E946.9
Vaccines and biological substances 978.0, 978.1, 978.2, 978.3, 978.4, 978.5, 978.6,
978.8, 978.9, 979.0, 979.1, 979.2, 979.3, 979.4,
979.5, 979.6, 979.7, 979.9, E948.0, E948.1,
E948.2, E948.3, E948.4, E948.5, E948.6, E948.8
E948.9, E949.0, E949.1, E949.2, E949.3, E949.4,
E949.5 E949.6, E949.7, E949.9
Note. Abbreviated reprint from “Medication-Related Adverse Outcomes in U.S. Hospitals
and Emergency Departments, 2008,” by J. Lucado, K. Paez, and A. Elixhauser, 2011,
HCUP Statistical Brief #109, p. 11-13. Copyright 2011 by Agency for Healthcare
Research and Quality. Reprinted with permission.
Though ICD-9 codes are generated for billing and reimbursement purposes,
several studies have noted the utility and current application of administrative data in
detecting adverse events (Bates et al., 2003; Cano & Rozenfeld, 2009; Hougland, Xu,
Pickard, Masheter, & Williams, 2006; Weingart et al., 2000). However, it should be
noted that the underreporting of ADEs in an administrative dataset may result in an
underestimate of ADE hospitalizations in this study (Cano & Rozenfeld, 2009; Hohl et
al., 2013).
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Encinosa & Bae (2013) identified hospital-acquired ADEs by redesigning
Lucado, Paez, & Elixhauser's (2011) algorithm to flag ADEs that were coded as not
being POA. For this study, the Lucado and colleagues algorithm was modified to flag
ADEs that were also coded as being POA. In other words, a hospital discharge was
identified as an ADE hospitalization if it was: (1) present on admission; and (2) had an
ICD-9 code that was considered an ADE. Both criteria were utilized in this definition to
ensure that ADEs were acquired prior to hospitalization. Following the protocol utilized
by Lucado et al. (2011), discharges with ICD-9 codes (965.00, 965.01, 969.6, 969.7,
E850.0, E854.1, E854.2, E935.0, E939.6, E939.7, E950.0-950.9, E962.0-E962.9, E980.0E980.9) that pertain to accidental poisonings, self-inflicted poisonings, and/or assault
were excluded. Additionally, hospitals that reported all diagnoses as being POA,
hospitals with over 20% of discharges with missing POA indicators for non-missing
diagnoses, and discharges with missing POA information for non-missing diagnoses were
excluded from the analysis.
Considering that only serious ADEs result in hospitalizations, ADE
hospitalizations among older adults will reflect the “safety and appropriateness of
ambulatory prescribing” (Thürmann, 2003). To calculate county-level rates, the
frequency of ADEs that result in hospitalization was divided by the population at risk of
an ADE or those that were taking any prescription medications. Data from the National
Health and Nutrition Examination Survey (NHANES) indicated that 89.7% of individuals
65 years and over have taken at least one prescription drug in the past 30 days (National
Center for Health Statistics, 2013). Given that approximately 90% of older adults took at
least one prescription medication, this analysis assumed that all older adults were at risk
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of an ADE. Thus, the ADE hospitalization rate calculation was the frequency of ADEs
that result in hospitalization divided by the population of 65 years and older in the
county. Additionally, to supplement the county ADE hospitalization rate analysis, a
discharge-level analysis was conducted. The discharge-level analysis determined what
factors were associated with having a higher odds of having an ADE hospitalization. The
second portion of Aim 1 analysis utilized an outcome variable of whether or not an ADE
hospitalization occurred.
The dependent variable for Aim 2 was the change in rates of ADE
hospitalizations between the years 2008 and 2011 that occur among the older adults in a
county. The identification of ADE hospitalization was identical to that used in the first
portion of Aim 1. The ADE hospitalization rate was calculated for the year 2008 and
2011 for each county.
Control Variables
County-level control variables were obtained from the ARHF, a database on
healthcare facilities maintained by the HRSA. These control variables were included:
total number of hospitals, total hospital beds, percent of residents with less than high
school education, percent of residents living in poverty, and percent of African American
residents.
Study Design
The county-level analysis of Aim 1 utilized a cross-sectional study design for the
year 2011 to determine the association between the rate of e-prescribing and ADE
hospitalizations among older adults at the county-level. The discharge-level analysis of
Aim 1 also utilized a cross-sectional study design to determine what factors were
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associated with increased odds of having an ADE hospitalization. State and county FIPS
codes were used to merge HCUP SID, ONC data, and the AHRF. Aim 2 utilized a preand post- intervention study design to examine the association between the 2008-2011
change in e-prescribing rates and the county-level rates of ADE hospitalizations.
Analytic Approach
Aim 1. Bivariate analysis assessed the correlation of the percentage of eprescribing providers with the rate of ADE hospitalizations at the county level. A
multivariate analysis, using linear regression, determined significant differences in the
rate of county-level hospitalizations for ADEs for patients 65 years and older, while
controlling for county-level characteristics. Additionally, for the analysis utilizing
discharge-level data, Wald chi-square tests determined the association of e-prescribing
adoption rates with the rate of ADE hospitalizations. Logistic regression determined the
adjusted odds of having an ADE hospitalization among older adults, while controlling for
patient- and county- level characteristics.
Aim 2. Student’s t-test assessed the difference of the 2008 and 2011 rate of ADE
hospitalizations and physician e-prescribing rates. Multivariate analysis using Poisson
regression modeled (as shown below) the number of ADE hospitalizations among
patients 65 years and older (num_ADE11). The total population of older adults
(den_ADE11) offset this model. Covariates for the model included the rate of ADE
hospitalizations for 2008 (rate_ADE08), the change in e-prescribing rate from 2008-2011
(diffrate_eRx), and county-level characteristics for 2011 (γ in equation below).
Overdispersion was detected and required negative binomial regression models for
estimation. Model: num_ADE11 = β0 + β1(rate_ADE08) + β2(diffrate_eRx) + Zγ + ε
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CHAPTER 4

MANUSCRIPT ONE

ASSOCIATION BETWEEN ELECTRONIC PRESCRIBING AND ADVERSE DRUG
EVENT HOSPITALIZATION RATES FOR OLDER ADULTS: AN ECOLOGICAL AND
DISCHARGE-LEVEL ANALYSIS1

1

Bhavsar, G.P., Probst, J.C., Bennett, K.J., Qureshi, Z., & Hardin, J.W. To be submitted
to Medical Care Research and Review
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Abstract
Purpose.
............At the county level, we sought to determine whether the proportion of physicians
using electronic prescribing (e-prescribing) was associated with the hospitalization rate
for adverse drug events (ADEs) among patients aged 65 and older.
Methods.
We conducted an ecological and discharge-level analysis of the relationship
between county e-prescribing rates and ADE hospitalizations. Data from the 2011 State
Inpatient Databases, the Office of the National Coordinator Health IT Dashboard, and the
Area Health Resource File were gathered for six states: Arizona, Florida, Maryland,
Michigan, New Jersey, and Washington. The analysis was restricted to adults 65 years
and older. The independent variable, the rate of e-prescribing, was an ecological measure
for both analyses. Our first analysis examined county rates of ADE hospitalization, while
the second analysis examined the odds that a discharge would have been ADE associated,
versus other causes. Multivariable linear and logistic regressions were utilized for countyand discharge- level analysis, respectively.
Results.
Results indicated that county e-prescribing rates were not significantly associated
with county ADE hospitalization rates among older adults (p=0.4705). Further, after
adjusting for patient, provider, health infrastructure, and community factors, the county e-
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prescribing rate was not a significant factor in determining the odds of an ADE
hospitalization.
Conclusion.
Though the adoption of e-prescribing has continued to increase throughout the
U.S., our findings indicate that population-level benefits, such as decreased ADE
hospitalization among older adults, have yet to be seen. Researchers and policy makers
must continue to monitor the population impact that the implementation of HITs is
having on the health of the nation.
Introduction
Patient safety and quality of care have received increased attention from the
healthcare industry since the release of the 1999 Institute of Medicine report, To Err is
Human. This heightened attention has continued to grow as tools to identify adverse drug
events and reactions are becoming widely available. Adverse drug events (ADEs),
defined as injuries that are the result of medication, are of particular public health
importance because of the increasingly high number of Americans taking prescription
drugs, particularly older Americans. Across 2007-2010, approximately 40% of
Americans aged 65 years and over used five or more prescription drugs in the past 30
days (U.S. Food and Drug Administration, 2013). Occurrences of ADEs are also seen in
older adults nearly 7 times more often than among adults younger than 65 years, making
them an important indicator of patient safety (Lucado, Paez, & Elixhauser, 2011).
ADEs that occur prior to hospital admissions are of particular interest because
they are three times more common than ADEs that originate during a hospital stay
(Weiss, Elixhauser, Bae, & Encinosa, 2013). Of all hospital stays, it is estimated that
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between 2.4% and 9.0% are caused by ADEs that are present at hospital admission (D.
Bates, Cullen, & Laird, 1995; Budnitz et al., 2005; Leape et al., 1999; von Laue,
Schwappach, & Koeck, 2003). von Laue et al. (2003) determined that over half of ADEs
were preventable. With the high risk and cost of ADEs in the older patient population, it
is essential to ensure that effective and appropriate ambulatory prescribing habits are
followed and ADEs that result in hospitalization are prevented (Thürmann, 2003;
Willlams, 2002).
Kaushal, Barker, & Bates (2001) describe the potential of health information
technology (HIT) to improve patient safety in the outpatient setting. Additionally, Bates
& Gawande (2003) argue that electronic prescribing (e-prescribing) provides a method to
reduce errors by preventing errors and adverse events. E-prescribing provides a tool to
overcome the common risk factors of ADEs, such as lack of communication among
concurrent prescribers (Boockvar et al., 2009; Green, Hawley, & Rask, 2007; Jena,
Goldman, Weaver, & Karaca-Mandic, 2014).
In an effort to increase the adoption of e-prescribing, federal legislation and
incentive programs have been established. These programs include the Medicare
Prescription Drug, Improvement, and Modernization Act of 2003, the e-prescribing
incentive program as part of the Medicare Improvements for Patients and Providers Act
of 2008, and most recently the electronic health record incentive program through the
Health Information Technology for Economic and Clinical Health Act of the American
Recovery and Reinvestment Act of 2009. The combination of incentives has resulted in
an increase in e-prescribing adoption from approximately 7% in December 2008 to 70%
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in April 2014 (Gabriel & Swain, 2014). However, whether the increase in HITs has
resulted in meaningful population health improvements is undetermined.
Previous studies examining the impact of HIT on ADEs have been limited to a
hospital setting and determining the rate of ADEs occurring within a hospital stay (D W
Bates et al., 1999; Colpaert et al., 2006; Devine et al., 2010; Evans et al., 1994, 1998;
Gandhi et al., 2005; Gurwitz et al., 2008; King, Paice, Rangrej, Forestell, & Swartz,
2003; Mullett, Evans, Christenson, & Dean, 2001; Pestotnik, Classen, Evans, & Burke,
1996; Steele et al., 2005; Upperman et al., 2005; van Doormaal et al., 2009). No studies
were found that examined the impact of HIT use in ambulatory settings on ADE
hospitalizations or provided a population-based approach. The population-based
approach of this study examines the impact of the Office of the National Coordinator for
Health Information Technology (ONC) call for interoperability among all parts of the
health care system, rather than focusing on individual patients. This study provides a
population-based approach to examine the association of e-prescribing on
hospitalizations caused by ADEs, specifically among older adults.
Methodology
Theoretical model
An ecological modification of Ancker, Kern, Abramson, & Kaushal's (2012) Triangle
Model was used as a theoretical framework for this analysis (See Figure 2.2). We
conducted separate county- and discharge-level analyses to determine the association
between e-prescribing and ADE hospitalization rates. The four main constructs of the
framework include properties of the technology, provider, community, and patient. We
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modified the framework to account for each of these constructs at an ecological level:
technology, adopters/providers, healthcare infrastructure, and community/patients.
Data sources
Data were drawn from three datasets: 2011 Healthcare Cost and Utilization Project
(HCUP) State Inpatient Databases (SID), the ONC Health IT Dashboard – Health IT
Adoption and Use dataset, and the Health Resources and Services Administration
(HRSA) Area Health Resource File (AHRF). Datasets were merged using state and
county Federal Information Processing Standards (FIPS) codes. Key data elements for
this study from HCUP SID include patient demographics, such as sex, age, race, number
of chronic conditions, and length of stay; principal diagnosis; and whether the diagnosis
was present on admission (POA) (HCUP Databases, 2014). The POA indicator allows for
the identification of ADEs that occurred in the community and are likely to be associated
with outpatient provider prescriptions, rather than during a hospital stay. This study was
exempt by the University of South Carolina Institutional Review Board.
Study Sample
Due to budgetary constraints and per-state costs for HCUP SID files, the analysis
was limited to data from 249 counties within 6 states: Arizona, Florida, Maryland,
Michigan, New Jersey, and Washington. States were chosen due to the availability of
patient residence and POA indicator data elements, while also allowing for the
representation of at least one state from each of the four major Census regions.
To ensure that our analysis did not inaccurately estimate the association between
e-prescribing and ADE hospitalizations, several criteria were used to exclude discharges,
hospitals, and counties from the county- and discharge- level analyses. Counties with
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missing electronic prescribing rates were excluded from both analyses (n=6). Hospitals
and discharges with missing or partial information were also excluded. Specifically,
hospitals that report all diagnoses as POA, and hospital with over 20% of discharges with
missing POA indicators for non-missing diagnoses were excluded. The number of
hospitals represented was reduced from 869 to 745 after hospital exclusion criteria were
applied. We also excluded discharges with missing age or age less than 65 years, missing
POA information for non-missing diagnoses, and missing county of residence. Lastly,
discharges for out-of-state patients were excluded from these analyses. The final study
population for the discharge level analysis consisted of 2,484,768 discharges across 243
counties.
In addition to the above criteria, the county-level analysis used one additional
exclusion criterion. To avoid artificially low ADE hospitalization rates, if a hospital was
excluded due to the criteria listed above, the county of the hospital was excluded from the
sample. Twelve hospitals were included despite not having county data available in the
SID. We deduced the location of these hospitals based on the county of patient residence
with the highest percentage of discharges. We chose not to exclude the counties of these
12 hospitals because while most of the hospital’s patients came from a single county,
those discharges represented less than 5% of county discharges (See Appendix A for
details). County data were also not available for the state of Michigan. The final sample
for the county-level analysis consisted of 111 counties.
Dependent variable
Following the algorithm utilized by Encinosa & Bae (2013), we modified the
Lucado et al. (2011) method to flag ADEs. To only identify ADEs that occurred within
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the community and outside of a hospitalization, our modification defines ADE
hospitalizations as hospital discharges that had [1] a POA indicator and [2] an
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9)
diagnosis code for an ADE. Both criteria were used to ensure that ADEs were acquired
prior to hospitalization. Lucado, Paez, & Elixhauser's (2011) list of ICD-9 codes and
external cause of injury codes were used to determine ICD-9 codes for ADEs. Discharges
with ICD-9 codes that pertain to accidental poisonings, self-inflicted poisonings, and/or
assault were not flagged as ADEs. For the county-level analysis, the ADE hospitalization
rate was calculated by dividing the number of ADE hospitalizations in the patient county
of residence in 2011 by the older adult population in the county in 2011. The dischargelevel analysis utilized a dichotomous indicator of having an ADE hospitalization.
Independent variable
The ONC Health IT Dashboard – Health IT Adoption and Use dataset was
utilized to determine the independent variable, the percentage of physicians e-prescribing
in each county. The ONC Health IT Dashboard is an open government project that
provides percentage of e-prescribers on the country’s largest e-prescribing network,
Surescripts, by county (Office of the National Coordinator for Health Information
Technology, 2014). Surescripts is utilized by nearly 95% of U.S. community pharmacies
(“Surescripts,” 2014b). Two out of three healthcare professionals utilized one of the top
ten electronic medical records, which includes medication history functionalities with the
ability for risk management of ADEs, drug-drug interactions, and drug-allergy
interactions via Surescripts (Surescripts, 2014a). Of the non-dominant EMR vendors,
65.1% (459 of 691 vendors) have medication history functionalities via Surescripts. The
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adoption rate of counties was categorized as either high/low when compared to the
median rate or into quartiles.
Control variables
Multivariable analyses control for potential confounders at two levels. At the
county level, the HRSA AHRF was the source for control variables. Adopters/providers
were determined through the AHRF by including the number of primary care physicians
per 1,000 population in the county (expressed in quartiles). Healthcare infrastructure was
represented by including the number of hospital beds per 1,000 population in the county
(expressed in quartiles), and whether the county had a hospital. Last, the community
variables utilized included whether a county was rural (defined by the 2003 Urban
Influence Code of greater than 3), the percentage greater than 65 years old, the
percentage of population living in poverty (continuous in county-level analysis;
expressed in quartiles for discharge-level analysis), the percent African American
population, and the percentage of the population with less than a high school education
(continuous in county-level analysis; divided into quartiles for discharge-level analysis).
At the discharge level, patient demographic information and whether a county was
designated a Health Professional Shortage Area (Whole, Partial, None) was also included
in the analysis. This included the patient sex, age group (65-74, 75-84, 85+),
race/ethnicity (White, African American, Hispanic, Other), number of chronic conditions
(0-20), and length of hospital stay in days.
Analytic Approach
A cross-sectional ecological study design was implemented to determine the
association of county e-prescribing rates with ADE hospitalization rates. Discharges were
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assigned to counties based on the patient county of residence. Unadjusted ADE rates
were estimated across county characteristics of interest. A multivariate analysis, using
linear regression, was used to identify county characteristics that influence county ADE
rates.
Second, a discharge-level analysis was used to determine whether the odds of
having an ADE hospitalization were associated with county e-prescribing rates.
Differences across county e-prescribing adoption rates were assessed using Wald chisquare tests (α = 0.05). Multivariate logistic regression was utilized to identify patient and
county characteristics that were associated with having an ADE hospitalization. Five
logistic regression models were conducted to determine the impact of each major
construct of the theoretical framework: Technology, Patient, Adopters/Providers,
Healthcare Infrastructure, and Community.
Results – County Analysis
Table 4.1 describes the counties in our dataset, by the e-prescribing rate of the
county. Low adoption counties had a proportionately larger African American population
and population with less than a high school education when compared to high eprescribing counties (p=0.0267 and p=0.0302, respectively). High e-prescribing counties
had a greater proportion of the population aged 65 years and older (p=0.0106)
Table 4.1 Descriptive Summary of County Characteristics by Electronic Prescribing
(E-Prescribing) Rates, 2011
County E-Prescribing Adoption Rate
High
Low
All
p-value,
Characteristics of Interest
Adoption Adoption
Counties
High vs.
Counties
Counties
(n=111)
Low
(n=61)
(n=50)
Adopters / Providers
Primary care physicians (per
1,000)
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0.00 – 0.36
0.37 – 0.53
0.54 – 0.70
0.71 – 1.86
Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 1.13
1.14 – 1.98
1.99 – 2.98
2.99 – 21.4
No hospital in county
Community
Rural
Population ≥ 65 years (%)
Population living in poverty (%)
African American population (%)
Population with < high school
education (%)

25.2
24.3
27.0
23.4

23.0
21.3
29.5
26.2

28.0
28.0
24.0
20.0

0.5422
0.4138
0.5156
0.4407

24.3
25.2
26.1
24.3
12.6

24.6
21.3
24.6
29.5
13.1

24.0
30.0
28.0
18.0
12.0

0.9425
0.2943
0.6841
0.1597
0.8603

40.5
17.2
16.4
12.2

32.8
18.8
15.6
9.9

50.0
15.2
17.3
15.0

0.0661
0.0106
0.2978
0.0267

10.5

9.7

11.5

0.0302

The median unadjusted ADE rate per 1,000 older adults was 0.67 for the counties
studied. No factors significantly related to unadjusted ADE hospitalization rates were
detected (See Table 4.2).
Table 4.2 Unadjusted Adverse Drug Event Rate (per 1,000 older adults) by County
Characteristics, 2011 (n=111 counties)
Unadjusted
Adverse
p-value,
Standard
Characteristics of Interest
Drug Event
compared to
Error
Rate per
referent
1,000
Technology
e-Prescribing Rate
0 – 27%
28 – 34%
35 – 45%
≥ 46% (referent)

0.71
0.74
0.64
0.60

0.08
0.06
0.05
0.06

1.0000
0.9178
1.0000

Adopters / Providers
Primary care physicians (per
1,000)
0.00 – 0.36
0.37 – 0.53
0.54 – 0.70

0.68
0.64
0.66

0.08
0.06
0.04

1.0000
1.0000
1.0000
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0.71 – 1.86 (referent)
Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 1.13
1.14 – 1.98
1.99 – 2.98
2.99 – 21.4 (referent)
Hospital availability
Hospital in county (referent)
No hospital in county

0.70

0.07

0.67
0.63
0.62
0.75

0.07
0.05
0.06
0.07

0.55
0.68

0.11
0.03

0.60
0.71

0.05
0.04

1.0000
1.0000
1.0000
0.1461

Community
Location
Rural
Urban (referent)

0.0972

In adjusted analysis (See Table 4.3), the e-prescribing rate was not significantly
associated with the county ADE rate among older adults. Counties without a hospital had
a significantly lower ADE rate than counties with a hospital (p=0.0305). In addition,
counties with higher African American populations had slightly higher ADE rates
(p=0.0377).
Table 4.3 Factors influencing Adverse Drug Event Rate (per 1,000) among older
adults, 2011 (n=111 counties)
p-value,
Standard
Characteristics of Interest
Estimate
compared
Error
to referent
Technology
e-Prescribing Rate
Adopters / Providers
Primary care physicians (per 1,000)
0.00 – 1.13
1.14 – 1.98
1.99 – 2.98
0.71 – 1.86 (referent)
Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 1.13
1.14 – 1.98
1.99 – 2.98
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-0.0015

0.0020

0.4705

0.0819
0.0153
0.0343
Ref.

0.1318
0.1027
0.0910
Ref.

0.5356
0.8815
0.7073
Ref.

0.1178
-0.0604
-0.0609

0.1278
0.1001
0.0904

0.3589
0.5475
0.5027

2.99 – 21.4 (referent)
No hospital in county (versus hospital
in county)
Community
Rural (versus Urban)
Population ≥ 65 years (%)
Population living in poverty (%)
African American population (%)
Population with < high school
education (%)

Ref.

Ref.

Ref.

-0.2739

0.1247

0.0305

-0.1030
-0.0040
0.0067
0.0063

0.0818
0.0056
0.0078
0.0030

0.2114
0.4861
0.3997
0.0377

-0.0071

0.0133

0.5982

Results – Discharge-level Analysis
Table 4.4 displays the characteristics of hospital discharges in the study
population, subset by the county e-prescribing rate. Discharges for patients who resided
in the highest e-prescribing counties were more likely male, between the ages of 65-74,
white, and had a shorter length of hospital stay. The counties in which these patients
reside have fewer primary care physicians, fewer hospital beds per population, are more
likely to be whole county HPSA, are more likely to be rural, and have close to median
levels of poverty and high school education levels.
Table 4.4 Characteristics of Hospital Discharges among Older Adults, by Electronic
Prescribing (E-Prescribing) Rates, 2011
County E-Prescribing Adoption Rate
p-value,
Characteristics of Interest
All
High
Low
High vs.
Counties
Adoption
Adoption
Low
All Discharges
Number of Discharges
Patient
Malea
Age Group
65 – 74
75 – 84
85+
Raceb
White
African American

100.0
2,484,768

52.5
1,304,420

47.5
1,180,348

44.2

45.1

43.3

<0.0001

38.3
37.5
24.2

39.2
37.6
23.2

37.3
37.5
25.3

<0.0001
0.0518
<0.0001

74.9
10.3

82.3
6.8

66.7
14.2

<0.0001
<0.0001
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Hispanic
Other
Number of chronic conditions,
mean
Length of stay, mean
Adopters / Providers
Primary care physicians (per
1,000)
0.00 – 0.57
0.58 – 0.71
0.72 – 0.84
0.85 – 1.85
Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 2.21
2.22 – 2.89
2.90 – 3.43
3.44 – 21.4
No hospital in county
Health Professional Shortage
Area (HPSA)
Whole
Partial
None
Community
Rural
Population living in poverty
0.0 – 11.8
11.9 – 15.4
15.5 – 17.8
17.9 – 36.0
Population with < high school
education
0.0 – 7.1
7.2 – 8.7
8.8 – 10.2
10.3 – 24.7
State
AZ
FL
MD
MI
NJ
WA

7.7
2.7

4.2
2.4

11.7
3.0

<0.0001
<0.0001

6.7

6.7

6.7

<0.0001

5.3

5.1

5.5

<0.0001

25.5
25.3
24.1
25.1

24.6
34.1
18.0
23.3

26.5
15.6
30.9
27.0

<0.0001
<0.0001
<0.0001
<0.0001

24.6
25.3
26.7
23.4
0.7

24.8
36.1
21.4
17.6
0.9

24.4
13.4
32.5
29.7
0.5

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

29.7
65.1
5.2

31.6
65.2
3.3

27.6
65.1
7.3

<0.0001
0.1368
<0.0001

9.3

10.1

8.4

<0.0001

24.9
25.7
24.4
25.0

20.8
30.4
26.2
22.7

29.5
20.6
22.4
27.6

<0.0001
<0.0001
<0.0001
<0.0001

25.7
24.2
25.0
25.2

24.9
24.9
33.6
16.6

26.6
23.4
15.4
34.7

<0.0001
<0.0001
<0.0001
<0.0001

9.9
39.7
8.9
18.7
15.2
7.6

17.5
41.3
8.5
13.9
8.2
10.7

1.6
37.9
9.5
24.1
22.9
4.1

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
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Notes:
All differences were assessed using Wald chi-square tests
a
17 discharges were missing sex
b
108,693 discharges were missing race
A total of 5,956 of 2,484,768 (0.24%) discharges were due to ADEs that occurred
in the community. The unadjusted proportion of all hospitalizations among persons 65
and older that included a community ADE was higher for counties with high eprescribing adoption rates (0.25 versus 0.22; see Table 4.5). Other factors that were
associated with proportionately more ADE hospitalizations included being between the
aged of 65-74 years, living in a county with more hospital beds per population, living
outside of a HPSA, and residing in Washington, Arizona, or Florida.
Table 4.5 Percent of Older Adult Discharges that Included a Community ADE, by
Electronic Prescribing (E-Prescribing) Rates, 2011
County E-Prescribing Adoption Rate
p-value,
Characteristics of Interest
All
High
Low
High vs.
Counties
Adoption
Adoption
Low
All Discharges (n=2,484,768)
Patient
Sexa
Male
Female
Age Groupb
65 – 74
75 – 84
85+
Race
White
African American
Hispanic
Other
Adopters / Providers
Primary care physicians
(per 1,000)
0.00 – 0.57
0.58 – 0.71
0.72 – 0.84

0.24

0.25

0.22

<0.0001

0.21
0.26

0.22
0.28

0.20
0.24

0.32
0.21
0.16

0.34
0.22
0.17

0.30
0.20
0.14

0.0180
0.0740
0.3472

0.25
0.23
0.19
0.23

0.26
0.25
0.24
0.22

0.23
0.22
0.17
0.25

<0.0001
<0.0001
<0.0001
0.0042

0.22
0.25
0.25

0.24
0.26
0.28

0.21
0.25
0.23

0.0935
<0.0001
<0.0001

0.8829
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0.85 – 1.85
Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 2.21
2.22 – 2.89
2.90 – 3.43
3.44 – 21.4
Number of hospitals in
county
0
1 or more
Health Professional
Shortage Area (HPSA)
Whole
Partial
None

0.23

0.25

0.21

0.0260

0.23
0.24
0.24
0.25

0.25
0.24
0.27
0.27

0.21
0.23
0.22
0.23

0.3581
<0.0001
<0.0001
<0.0001
n/a

0.23
0.24

0.25
0.25

n/a
0.22

0.26
0.23
0.21

0.27
0.25
0.27

0.26
0.21
0.19

Community
Rurality
Urban
0.24
0.26
Rural
0.22
0.22
Population living in poverty
0.0 – 11.8
0.21
0.22
11.9 – 15.4
0.25
0.26
15.5 – 17.8
0.26
0.28
17.9 – 36.0
0.24
0.25
Population with < high
school education
0.0 – 7.1
0.24
0.26
7.2 – 8.7
0.25
0.26
8.8 – 10.2
0.26
0.27
10.3 – 24.7
0.21
0.22
State
AZ
0.28
0.28
FL
0.25
0.26
MD
0.24
0.22
MI
0.22
0.24
NJ
0.18
0.19
WA
0.29
0.29
Notes:
All differences were assessed using Wald chi-square tests, α = 0.05
n/a – sample size < 5
a
17 discharges were missing sex
b
108,693 discharges were missing race
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0.4004
0.1806
<0.0001
0.6148

0.22
0.22
0.21
0.25
0.22
0.22

<0.0001
<0.0001
<0.0001
<0.0001

0.22
0.23
0.25
0.21

0.4082
0.2071
<0.0001
<0.0001

0.28
0.24
0.26
0.21
0.17
0.29

<0.0001
0.7379
<0.0001
<0.0001
<0.0001
<0.0001

The multivariate logistic model (see Table 4.6) estimated the odds of having an
ADE hospitalization versus other diagnoses. Because our approach is based on all
hospitalizations rather than all persons, our model controls for potential differences in the
likelihood of hospitalization associated with regional variation in practice patterns. The
first model included only the county e-prescribing rate. It found that residents of a county
with a 27 -35% adoption rate were less likely to have an ADE hospitalization when
compared to residents living in counties with an adoption rate of over 48%. When patient
demographic information was added into the model (model 2), the odds of residents of a
county with 27-35% adoption rate no longer were significant. Other factors that were
associated with having higher odds of an ADE hospitalization, when taking patient
demographics into account, included being female and having additional chronic
conditions. When adding the number of primary care physicians per 1,000 population
into the model (model 3), being female, having additional chronic conditions, and living
in a county that have 0.72 – 0.84 primary care physicians per 1,000 population were
significantly associated with increased odds of ADE hospitalizations. Model 4 took
healthcare infrastructure into account there were no changes in significant factors. The
final model (model 5) included all the previous variables and community factors. Model
5 indicates that the county e-prescribing rates are not significantly associated with the
odds of an older adult having an ADE hospitalization. Additionally, the model indicates
that the odds of an ADE hospitalization are higher for females, having more chronic
conditions, living in counties with 8.8 – 10.2% of the population having less than a high
school education, and living in Maryland or Washington.
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Table 4.6 Adjusted Odds of Having an Adverse Drug Event Hospitalization among Older Adults, 2011
Characteristics of Interest
Technology
Electronic Prescribing Rate
0 – 26%
27 – 35%
36 – 47%
≥ 48%
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Patient
Sex
Male
Female
Age Group
65 – 74
75 – 84
85+
Race
White
African American
Hispanic
Other
Each additional chronic condition
Each additional day in length of stay
Adopters / Providers
Primary care physicians (per 1,000)
0.00 – 0.57
0.58 – 0.71
0.72 – 0.84
0.85 – 1.85
Healthcare Infrastructure
Hospital beds (per 1,000)

Model 1
OR (95% CI)

Model 2
OR (95% CI)

Model 3
OR (95% CI)

Model 4
OR (95% CI)

Model 5
OR (95% CI)

0.93 (0.86 – 1.00)
0.85 (0.79 – 0.92)
1.04 (0.97 – 1.11)
Ref.

0.95 (0.88 – 1.02)
0.93 (0.86 – 1.01)
1.03 (0.96 – 1.10)
Ref.

0.94 (0.88 – 1.02)
0.89 (0.82 – 0.96)
0.99 (0.93 – 1.07)
Ref.

0.94 (0.87 – 1.01)
0.89 (0.82 – 0.97)
1.02 (0.95 – 1.11)
Ref.

1.08 (1.00 – 1.17)
0.94 (0.86 – 1.03)
1.07 (0.98 – 1.17)
Ref.

Ref.
1.33 (1.26 – 1.41)

Ref.
1.34 (1.27 – 1.41)

Ref.
1.33 (1.26 – 1.41)

Ref.
1.33 (1.26 – 1.41)

Ref.
0.65 (0.61 – 0.69)
0.46 (0.43 – 0.50)

Ref.
0.65 (0.61 – 0.68)
0.46 (0.43 – 0.50)

Ref.
0.65 (0.61 – 0.69)
0.46 (0.43 – 0.50)

Ref.
0.65 (0.61 – 0.69)
0.46 (0.43 – 0.50)

Ref.
0.89 (0.81 – 0.97)
0.78 (0.70 – 0.87)
0.93 (0.79 – 1.09)
1.04 (1.03 – 1.05)
0.93 (0.92 – 0.93)

Ref.
0.87 (0.80 – 0.95)
0.73 (0.65 – 0.82)
0.93 (0.79 – 1.09)
1.04 (1.03 – 1.05)
0.93 (0.79 – 1.09)

Ref.
0.86 (0.79 – 0.94)
0.74 (0.66 – 0.82)
0.93 (0.79 – 1.09)
1.04 (1.03 – 1.05)
0.93 (0.92 – 0.93)

Ref.
0.87 (0.80 – 0.96)
0.75 (0.67 – 0.85)
0.93 (0.79 – 1.09)
1.04 (1.03 – 1.05)
0.93 (0.92 – 0.93)

0.93 (0.86 – 1.01)
1.05 (0.97 – 1.13)
1.20 (1.11 – 1.29)
Ref.

0.97 (0.88 – 1.06)
1.04 (0.95 – 1.13)
1.20 (1.10 – 1.31)
Ref.

0.94 (0.85 – 1.05)
0.92 (0.83 – 1.01)
0.96 (0.86 – 1.07)
Ref.

0.00 – 2.21
2.22 – 2.89
2.90 – 3.43
3.44 – 21.4
Number of hospitals
0
1 or more
Health Professional Shortage Area
(HPSA)
Whole
Partial
None
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Community
Rurality
Urban
Rural
Population living in poverty
0.0 – 11.8
11.9 – 15.4
15.5 – 17.8
17.9 – 36.0
Population with < high school
education
0.0 – 7.1
7.2 – 8.7
8.8 – 10.2
10.3 – 24.7
State
AZ
FL
MD
MI
NJ

0.92 (0.84 – 1.01)
0.92 (0.84 – 1.00)
0.95 (0.87 – 1.04)
Ref.

0.91 (0.82 – 1.01)
0.89 (0.81 – 0.98)
0.97 (0.89 – 1.06)
Ref.

0.96 (0.70 – 1.31)
Ref.

1.08 (0.79 – 1.48)
Ref.

1.12 (0.98 – 1.29)
1.03 (0.90 – 1.18)
Ref.

0.95 (0.81 – 1.12)
0.87 (0.75 – 0.93)
Ref.

Ref.
0.84 (0.75 – 0.93)
Ref.
1.05 (0.94 – 1.17)
1.11 (0.99 – 1.26)
1.08 (0.95 – 1.24)

Ref.
1.07 (0.94 – 1.21)
1.13 (1.02 – 1.25)
1.09 (0.98 – 1.21)
Ref.
1.13 (0.96 – 1.34)
1.20 (1.06 – 1.36)
1.00 (0.87 – 1.13)
0.86 (0.76 – 0.97)

WA
Note: Bold indicates significantly different from the reference group (α=.05)
108,734 observations were excluded from the model due to missing race variable and/or age variable

1.32 (1.12 – 1.55)
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Discussion
Overall Findings
Neither the county- nor the discharge- level analysis found e-prescribing rates at
the county level to be significantly associated with community-occurring ADE
hospitalizations. Previous research in inpatient settings, including pediatric hospitals and
intensive care units, have found no direct effect on ADEs (Evans et al., 1995; King et
al.,2003; Upperman et al., 2005; van Doormaal et al., 2009). Research in other settings,
such as a primary care clinic and long-term care facility, have demonstrated improved
adherence to best-practice guidelines, but have been unable to demonstrate a reduction in
ADE rates (Gurwitz et al., 2008; Steele et al., 2005).
Rogers' (1995) Diffusion of Innovation theory explains that the rate of innovation
adoption gains momentum after 20% and continues to increase at an accelerated rate. The
mean e-prescribing rate for studied counties in 2011 was 36.5%. Rogers’ theory
categorizes adopters during this stage in the “early majority”. The rate of adoption was in
the process of accelerating during our study time period. The national rate of eprescribing increased from 7% in December 2008 to 70% in April 2014 (Gabriel &
Swain, 2014). Thus, theoretically, our studied counties comprised of only early adopters.
Westphal & Shortell (2014) found that early adopters of total quality management
practices were more likely to adapt technologies to improve efficiencies within their
organizations, while late adopters were more likely to conform to norms by adopting well
established programs. Studies also demonstrate that the true value of technology is how it
is utilized by individuals and organizations (Karsh, Weinger, Abbott, & Wears, 2010;
Prince & Herrin, 2007). These studies demonstrate the need to address organizational and
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human factor changes to avoid unintended consequences (Damberg et al., 2009;
Edmondson, Bohmer, & Pisano, 2001; Menachemi, Burke, & Brooks, 2004; Nanji et al.,
2011). An explanation for our lack of association may be that early adopters did not
demonstrate early gains in patient safety indicators because they were still adapting their
use of the technology into their organization to improve long-term efficiencies. Thus, the
focus on long-term gains restricts our ability to view short-term improvements. Though
we hypothesized increased e-prescribing rates would be associated with lower ADE
hospitalization rates, we believe that the low level of adoption of e-prescribing nationally
in 2011 may have inhibited our ability to detect any differences.
County-level analysis findings
In the county-level analysis, two major factors were significantly associated with
county-level ADE hospitalization rates: the percentage of African American population
in the county (p=0.0377) and whether the county had a hospital (p=0.0305).
Discharge-level analysis findings
The discharge-level analysis identified that being female and having a greater
number of chronic conditions was associated with an increased odds of ADE
hospitalization, while being older than 75 years, living in HPSA or rural areas, being
African American or Hispanic, and having longer hospital stays were associated with
reduced odds of ADE hospitalizations.
Living in Maryland and Washington resulted in higher odds of ADE
hospitalizations when compared to Arizona. The state variation in odds of an ADE
hospitalization cannot be explained by variations in e-prescribing rates or POA reporting
experience. In 2011, the states studied varied in e-prescribing rates from lowest to highest
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in the following order: New Jersey (22%), Florida (26%), Maryland (29%), Arizona
(33%), Michigan (37%), and Washington (37%) (Office of the National Coordinator for
Health Information Technology, 2014). Additionally in 2011, Arizona, Michigan, New
Jersey and Washington had been reporting POA data to HCUP for 3 years, while Florida
and Maryland had been reporting HCUP POA data for 4 years.
Comparing the County- and Discharge-level analyses
While the county-level analysis found that counties without a hospital had lower
ADE hospitalization rates than counties with a hospital, the discharge-level analysis did
not detect a similar difference. However, the discharge-level findings did identify that
living in rural areas results in reduced odds of having an ADE hospitalization. Over half
(57%) of the studied counties without a hospital were located in rural areas. Literature
shows that rural areas tend to have lower adoption of HITs that urban areas (Bahensky,
Jaana, & Ward, 2008). A possible explanation for this phenomenon may be that areas
with limited healthcare providers and infrastructure may communicate and coordinate the
prescription management of patients better than areas with higher provider saturation.
Additional research is necessary to determine why ADE hospitalization rates were lower
in rural counties when compared to urban counties and why areas without hospitals had
lower odds of having an ADE hospitalization.
While the percentage of African American populations in a county was
significantly associated with higher county-level ADE hospitalization rates, the
discharge-level analysis revealed that if the race of the patient was African American the
odds of an ADE hospitalization were reduced. While the county-level analysis used the
percentage of African American populations in the county as a proxy for patient
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demographics, the discharge-level analysis indicated how the actual race of the patient
impacts their odds of having an ADE hospitalization. Future studies should aim to
determine racial differences in susceptibility and severity of ADEs.
Limitations
This analysis may underestimate ADE hospitalization due to the underreporting of
ADEs in administrative datasets (Cano & Rozenfeld, 2009; Hohl et al., 2013). However,
studies have noted the utility of using administrative data in detecting adverse events
(David W Bates et al., 2003; Cano & Rozenfeld, 2009; Hougland, Xu, Pickard, Masheter,
& Williams, 2006; Weingart et al., 2000). This analysis was also restricted to six states,
which limits the generalizability of its findings.
We limited this analysis to ADE hospitalizations because they provide insight into
the safety of ambulatory prescribing (Thürmann, 2003). However, the definition utilized
in this study was broad and further analysis should indicate whether ADE hospitalizations
are considered preventable, potential, or non-preventable. This distinction will allow for a
better understanding of the performance of technologies, such as e-prescribing. Previous
studies have found decreases in preventable and potential ADEs (D W Bates et al., 1998,
1999). Also, while we only examined one HIT, e-prescribing, other technologies have
also shown potential to decreasing ADEs and increasing patient safety. Given that eprescribing can be viewed as an entry-level system when compared to more
comprehensive HITs, this study provides a stepping stone to determine the impact HIT
adoption is having throughout our nation (Bell & Friedman, 2005). Lastly, we used an
ecological measure for e-prescribing rates. This limited our ability to determine whether a
patient with an ADE hospitalization was seen at a practice with e-prescribing capabilities.
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Conclusions
Our results suggest that county e-prescribing rates are currently not a significant
factor in county-level ADE hospitalizations or the odds of having an ADE
hospitalization. Further research and monitoring is necessary to determine the potential
impact of e-prescribing on population-level patient safety indicators.
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CHAPTER 5

MANUSCRIPT TWO

ASSOCIATION BETWEEN 2008-2011 CHANGE IN ELECTRONIC PRESCRIBING
AND ADVERSE DRUG EVENT HOSPITALIZATION RATES: A COUNTY-LEVEL
ANALYSIS OF FIVE U.S. STATES1

1

Bhavsar, G.P., Probst, J.C., Bennett, K.J., Qureshi, Z., & Hardin, J.W. To be submitted
to Health Policy and Technology.
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Abstract
Purpose.
We sought to determine whether increases in the proportion of physicians using
electronic prescribing (e-prescribing) in a county were associated with decreases in the
hospitalization rate for adverse drug events (ADE) among patients aged 65 and older.
Methods.
We examined 76 counties from Arizona, Florida, Maryland, New Jersey, and
Washington, for which we had e-prescribing data for 2008 and 2011, using discharge
data from the State Inpatient Databases. ADE discharge rates were calculated for adults
65 years and older. E-prescribing data were obtained from the Office of the National
Coordinator Health IT Dashboard; population data from the Area Health Resource File.
Using negative binomial regression, we modeled the ADE hospitalization rate among
older adults in 2011 based on the ADE hospitalization rate in 2008, the change in eprescribing rates, and county characteristics.
Results.
Change in e-prescribing rates was not significantly associated with the change in
ADE hospitalization rates; no other county characteristics were found to be significant
factors. As the 2008 ADE hospitalization rate increased by 1.0 per 1,000 older adults, the
relative risk of ADE hospitalizations among older adults in 2011 multiplied by 1.84
(p<0.0001).
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Conclusion.
While the change in e-prescribing has not been associated with the change in
ADE hospitalization rates, it may be too early to detect population-level changes due to
the implementation of health information technologies, such as e-prescribing.
Introduction
Adverse drug events (ADEs), defined as injury or harm caused by a prescription
medication, are of particular public health importance due to the increasing number of
Americans taking prescription drugs. Nickel et al. (2013) estimate that for each additional
drug taken by an individual there is a 10% increase in probability of suffering from a
drug-related problem. Data in 2007-2010 indicate that approximately 67% of adults 65
years and older took three or more prescription drugs within a 30 day time period (U.S.
Department of Health and Human Services, 2013).
Older adults also experience ADEs nearly seven times more often than adults
youngers than 65 years (Lucado, Paez, & Elixhauser, 2011). The most serious type of
ADE, an ADE resulting in hospitalization, reflects the safety and appropriateness of
ambulatory prescribing (Thürmann, 2003). ADE hospitalizations are three times more
likely to be present on admission than to occur during a hospital stay (Weiss, Elixhauser,
Bae, & Encinosa, 2013). Preventing ADE hospitalizations and ensuring safe and
appropriate prescribing measures are taken is vital to the safety of all patients in the U.S.
healthcare system, particularly the elderly due to the multitude of chronic conditions they
might suffer from resulting in polypharmacy making them an easy target for ADEs.
One potential method to prevent ADEs is through the use of health information
technologies (HITs), such as electronic prescribing (e-prescribing). E-prescribing is the
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electronic transmission of prescription information from the point of patient care. This
allows for the communication of prescriptions that are clean and free of ambiguities
(Figge, 2009). Additionally, health care providers are able to decrease ADEs through the
use of medication history tools that allow for drug-drug and drug-allergy interaction
checks. These potential benefits, coupled with federal incentive programs, have resulted
in an increase of e-prescribing from 7% in 2008 to 70% in 2014 (Gabriel & Swain, 2014).
Using the Berwick, Nolan, & Whittington's (2008) Triple Aim call for the
examination of population health impact and the Office of the National Health
Coordinator’s (ONC) call for interoperability among all parts of the healthcare system,
this study aims to examine the association between the change from 2008-2011 in eprescribing rates and the change in ADE hospitalizations among older adults at an
ecological-level.
Methodology
Theoretical model
Ancker, Kern, Abramson, & Kaushal's (2012) Triangle Model was modified to
take an ecological approach for this study (see Figure 2.2). The model builds on the
classic Donabedian (1988) Structure-Process-Outcome framework to evaluate the impact
of HIT on healthcare quality and patient safety. The five main constructs of this
framework are innovation/technology, adopter/provider, health infrastructure,
community, and consequences/outcomes.
Data sources
Three datasets were merged using the state and county Federal Information
Processing Standards (FIPS) codes for this analysis: 2008 and 2011 Healthcare Cost and
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Utilization Project (HCUP) State Inpatient Databases (SID), the ONC Health IT
Dashboard – Health IT Adoption and Use dataset, and the Health Resources and Services
Administration Area Health Resource File (AHRF). This study was categorized as
“exempt status” by the University of South Carolina Institutional Review Board, due to
the use of de-identified secondary data.
Study Sample
The study was limited to the 166 counties in Arizona, Florida, Maryland, New
Jersey, and Washington, due to budgetary constraints. These states were selected because
they reported key data elements, such as ICD-9 diagnosis codes and present on admission
indicators, in HCUP SID for both years of interest. Exclusion criteria at the discharge-,
hospital-, and county-level are outlined in Table 5.1.
Additionally, to avoid artificially low ADE hospitalization rates, if a hospital was
excluded from the analysis, we excluded the entire county in which the hospital was
located. Twelve hospitals in 2011 and eleven hospitals in 2008 did not have county data
available in SID. Using the patient county of residence with the highest percentage of
discharges from the hospital, we attempted to determine the hospital county for these 23
hospitals (See Appendix A). We ultimately decided not to exclude the counties of the 23
hospitals with missing county data from the analysis because these hospitals made up less
than 5% of all discharges in the most likely county. The final study population consisted
of 76 counties.
Table 5.1 Exclusion Criteria for association between 2008-2011 change in electronic
prescribing and adverse drug event hospitalization rates analysis
Discharge-level
 missing age
 missing present on admission (POA) information for non-missing diagnoses
 missing county of residence
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patients younger than 65 years old
ICD-9 codes that pertain to accidental poisonings, self-inflicted poisonings, and/or
assault
out-of-state patients

Hospital-level
 report all diagnoses as POA
 over 20% of discharges with missing POA indicators for non-missing diagnoses
County-level
 missing electronic prescribing rates for either 2008 or 2011
Dependent variable
ADE hospitalizations were flagged by inverting the approach used by Encinosa &
Bae (2013). Encinosa & Bae (2013) defined ADEs that occurred during a hospitalization
as those discharges that [1] were not flagged as being present on admission (POA), but
[2] did have one of the ICD-9 diagnosis codes listed by Lucado, Paez, & Elixhauser
(2011). Rather than excluding discharges that were flagged as POA, we included those
ADEs as having occurred outside of a hospitalization. That is, if a discharge had an ICD9 diagnosis code that was determined to be an ADE and had a POA indicator flagged, we
determined that ADE to be acquired prior to hospitalization. ADEs that occurred during a
hospitalization were not included in this analysis, as they were not representative of the
safety of ambulatory prescribing. The county ADE hospitalization rate was calculated by
dividing the number of ADE hospitalizations for older adults in the county by the older
adult population in the county.
Independent variable
The percentage of physicians e-prescribing in each county was determined using the
ONC Health IT Dashboard – Adoption and Use dataset. The ONC Health IT Dashboard
provides the percentage of physicians e-prescribing on the largest e-prescribing network,
Surescripts (Office of the National Coordinator for Health Information Technology,
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2014). Surescripts information is used by over 95% of U.S. community pharmacies and
provides functionalities to reduce the risk of ADEs and drug interactions (Surescripts,
2014). The difference between the 2008 and 2011 e-prescribing rates were taken for each
county and used as the main independent variable for this analysis.
Control variables
The multivariable analysis controlled for potential confounders in this study.
County-level variables were gathered from the HRSA AHRF to represent each construct
in our model. Adopters/providers are represented by the number of primary care
physicians per 1,000 in the county (quartiles). The healthcare infrastructure of the county
is represented by the number of hospital beds per 1,000 in the county (quartiles), whether
the county has a hospital (categorized as 0 and 1 or more), and whether the county is
designated as a whole county health professional shortage area (HPSA). Variables
representing the community include the county location (urban/rural), the percentage of
the population that is greater than or equal to 65 years old (quartiles), and the percentage
of the population with less than a high school education (quartiles).
Analytic Approach
A pre- and post- ecological study design was used to determine the association
between the change in e-prescribing rates and ADE hospitalization rates at the countylevel. Discharges were assigned to counties based on the patient county of residence. A
comparison of study counties to other U.S. counties determined any differences among
county characteristics. Differences among the independent and dependent variables based
on county characteristics were also conducted separately using one-way analysis of
variance (ANOVA) to determine if county characteristics were associated with changes
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in either e-prescribing rates or ADE hospitalization rates. Lastly, a multivariate analysis
was conducted using negative binomial regression to model the number of ADE
hospitalizations for older adults in 2011. This model was offset by the natural logarithm
of the population over 65 years old in the county. Covariates included the ADE rate for
2008, the change in e-prescribing from 2008-2011, and county-level characteristics. The
adjusted incident risk ratios (IRR) were calculated by the exponentiation of the model
estimate.
Results
Table 5.2 compares the 76 studied counties to the remaining U.S. counties.
Overall, studied counties had more primary care physicians (p<0.0001) and hospitals
(p<0.0001), were less likely to be rural (p<0.0001), and had a larger population
(<0.0001).
Table 5.2 Study County Characteristics and other U.S. Counties, 2011
Other U.S.
Study Counties
Counties
(n=76)
(n=3,072)
Characteristics of Interest
Std.
Std.
Mean
Mean
Dev.
Dev.
Technology
Change in Electronic
Prescribing Rate from 2008 to
2011

p-value

30.2

17.5

32.61

19.9

0.7750

164.8

241.9

70.8

254.3

<0.0001

0.6

0.3

0.5

0.4

0.0234

Healthcare Infrastructure
Number of hospitals in county
Hospital beds (per 1,000)

3.1
2.5

3.1
1.9

2.0
3.3

4.2
4.7

<0.0001
0.9164

Community
Rural county (%)*

36.8

-

66.0

-

<0.0001

Adopters / Providers
Number of primary care
physicians
Primary care physicians (per
1,000)
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Total population
232,673 261,568 95,673 316,725 <0.0001
Population ≥ 65 years (%)
17.7
7.1
16.1
4.1
0.5816
Population with < high school
10.4
4.2
11.3
4.9
0.1453
education (%)
Note:
Comparisons conducted using Wilcoxon-Mann-Whitney test for continuous variables
*Comparisons conducted using Wald chi-square test for categorical variables
1
Change in e-prescribing rate based on 1,689 counties with available e-prescribing data
The rate of e-prescribing increased from 7.3% in 2008 to 37.5% in 2011 among
studied counties, with an average change of 30.2%. The number of hospitals in a county
was a significant factor in determining the change in e-prescribing rate from 2008 to 2011
(p=0.0059; See Table 5.3). Counties without a hospital had a greater increase in eprescribing adoption when compared to counties with 2 or more hospitals.
Table 5.3 Change in Electronic Prescribing (e-Prescribing) between 2008 and 2011,
by county characteristics (n=76 counties)
Change in eCharacteristics of Interest
prescribing from
p-value2
2008 – 20111
Adopters / Providers
Primary care physicians (per 1,000)
0.00 – 0.43
0.44 – 0.55
0.56 – 0.72
0.73 – 1.85 (referent)

0.8729
33.3
24.2
30.8
32.0

Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 1.35
1.36 – 2.15
2.16 – 3.02
3.03 – 10.3 (referent)
Number of hospitals
0
1
2 or more (referent)
Health Professional Shortage Area (HPSA)
No HPSA
Whole County HPSA
Community
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0.2590
37.1
27.6
25.6
32.9
0.0059
55.7
34.6
26.6
0.2460
31.9
27.0

Location
0.1744
Urban
32.3
Rural
26.6
Population ≥ 65 years (%)
0.8767
9.3 – 12.3 (referent)
29.1
12.4 – 15.9
29.0
16.0 – 21.0
32.6
21.1 – 45.5
30.7
Population with < high school education (%)
0.2169
3.4 – 7.4 (referent)
31.9
7.5 – 9.3
31.5
9.4 – 12.1
30.4
12.2 – 22.7
27.0
Notes:
1
Calculated values are mean county level change: 2011 – 2008.
2
p-value tests significance of factor in estimating change in e-prescribing rate from
2008-2011
Bold indicates a significant difference from referent group (used ANOVA w/ Bonferroni
adjustment α=0.05/k, where k is the number of multiple comparisons)
Table 5.4 depicts whether the change in ADE hospitalization rates are associated
with county characteristics. Overall, the ADE hospitalization rate decreased from 0.71
per 1,000 persons in 2008 to 0.65 per 1,000 in 2011 (p=0.2033, data not in table). No
county characteristics were associated with the change in ADE rate from 2008 to 2011.
Table 5.4 Change in ADE Hospitalization Rate (per 1,000 older adults) between
2008 and 2011 (n = 76 counties), by county characteristics
Change in ADE Rate
Characteristics of Interest
from
p-value2
2008 – 20111
Adopters / Providers
Primary care physicians (per 1,000)
0.00 – 0.43
0.44 – 0.55
0.56 – 0.72
0.73 – 1.85 (referent)

-0.18
-0.04
0.00
0.02

Healthcare Infrastructure
Hospital beds (per 1,000)
0.00 – 1.35
1.36 – 2.15
2.16 – 3.02

0.02
-0.09
0.00

0.1272

0.3845
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3.03 – 10.3 (referent)
Number of hospitals
0
1
2 or more
Health Professional Shortage Area (HPSA)
No HPSA
Whole County HPSA

-0.11
0.2117
-0.39
-0.08
-0.02
0.9522
-0.05
-0.05

Community
Location
0.2553
Urban
-0.02
Rural
-0.11
Population ≥ 65 years (%)
0.6775
9.3 – 12.3 (referent)
0.00
12.4 – 15.9
-0.11
16.0 – 21.0
-0.17
21.1 – 45.5
0.04
Population with < high school education (%)
0.1970
3.4 – 7.4 (referent)
0.01
7.5 – 9.3
0.02
9.4 – 12.1
-0.02
12.2 – 22.7
-0.21
Notes:
1
Calculated values are means
2
p-value tests significance of factor in estimating change in ADE hospitalization rate
from 2008-2011
No significant differences from referent group were found (used ANOVA w/ Bonferroni
adjustment α=0.05/k, where k is the number of multiple comparisons)
Multivariable analysis indicated that the only significant factor in determining the
ADE hospitalization rate among older adults in 2011 was the 2008 ADE hospitalization
rate. Model 1included the ADE hospitalization rate for 2008 and the change in eprescribing rate from 2008 to 2011. Only the ADE hospitalization rate for 2008 was
shown as a significant factor in predicting the ADE hospitalization rate for 2011 in model
1. Model 2 included county-level characteristics to describe the adopters/providers,
healthcare infrastructure, and community. In model 2, as the ADE hospitalization rate for
2008 increased by 1.0 per 1,000 older adults, the relative risk of ADE hospitalizations
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among older adults multiplied by 1.84 (p<0.0001). No other characteristics were found to
be significant factors.
Table 5.5 Negative Binomial Regression for Number of Older Adult ADE
Hospitalizations in 2011 (n = 76 counties)
Model 1
Model 2
Characteristics of Interest
a
IRR
p-value IRRa
p-value
ADE Hospitalization Rate (per 1,000) for 2008

1.712

0.0001

1.843

<0.0001

0.996

0.1244

0.994

0.0678

Adopters / Providers
Primary care physicians (per 1,000)
0.00 – 0.43
0.44 – 0.55
0.56 – 0.72
0.73 – 1.85 (referent)

1.023
1.008
0.972
Ref.

0.8603
0.9386
0.7671
Ref.

Healthcare Infrastructure
Number of hospitals
0
1
2 or more (referent)

0.583
1.022
Ref.

0.3770
0.8645
Ref.

Technology
Change in Electronic Prescribing (eprescribing) Rate from 2008-2011

Community
Rural
0.857
0.1735
Population with < high school education (%)
3.4 – 7.4 (referent)
Ref.
Ref.
7.5 – 9.3
1.035
0.7171
9.4 – 12.1
1.145
0.2610
12.2 – 22.7
0.848
0.2301
Notes:
a
Incident Rate Ratios (IRR) were calculated by the exponentiation of the model estimate
Discussion
The adjusted negative binomial regression revealed that the change in eprescribing rate was not a significant factor in the change in ADE hospitalization rates
from 2008-2011. The ADE hospitalization rate for 2008 was a significant factor in
determining the ADE hospitalization rate from 2011.
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The rate of e-prescribing has increased dramatically nationwide since 2008
(Gabriel & Swain, 2014). Two key policies, the Medicare Improvements for Patients and
Providers Act and the Medicare and Medicaid Electronic Health Record incentive
programs, have provided financial incentives to encourage providers to use e-prescribing.
In our studied counties, the rate of e-prescribing increased from 7.3% in 2008 to 37.5% in
2011. Low adoption rates within our sample of counties indicate that a majority of
providers were not using e-prescribing, even in 2011. However, the e-prescribing countylevel rates in our sample were not significantly different from other U.S. counties.
Though we had hypothesized that as the rate of e-prescribing increased from 2008
to 2011, the rate of ADE hospitalizations would decrease at the county-level, we believe
the low e-prescribing adoption rates may have inhibited our ability to see such an
association. Under Rogers' (1995) Diffusion of Innovation theory, our 2008 study sample
forms the innovators and early adopters and our 2011 study sample forms the early
adopters and early majority of e-prescribing adopters. Studies have shown that early
adopters are more likely to alter the technology to improve their organizational
efficiencies (Westphal & Shortell, 2014). The physicians in our study counties, as early
adopters, may have been adapting the technologies to their organizational needs. The
focus on long-term benefits may have prevented our ability to demonstrate an association
with short-term benefits in ADE hospitalization rates. Since e-prescribing can be viewed
as an entry level HIT, continued research and monitoring may indicate benefits over the
coming years as e-prescribing becomes mainstream.
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Limitations
The inherent limitations of using an administrative dataset that was generated for
reimbursement purposes apply to this study (Bates et al., 2003). Though ADEs are
underreported in administrative datasets, using ICD-9 diagnosis codes to identify ADEs
is common practice (Hohl, Karpov, Reddekopp, & Stausberg, 2013). Only ADE
hospitalizations that were acquired outside of the hospital were examined in this study,
while ADEs can also present themselves within a hospital stay, in outpatient settings, and
as treat-and-release emergency room visits (Honigman et al., 2001; Lucado et al., 2011;
Weiss et al., 2013). However, Weiss, Elixhauser, Bae, & Encinosa (2013) found that
ADEs are three times more likely to be present on admission than occur during a
hospitalization.
This study was limited to county-level characteristics and did not take individual
patient characteristics into account. Individual patient characteristics, such as
comorbidities and illness severity, have shown to increase the likelihood of adverse drug
reactions (Sikdar et al., 2012). Additionally, the independent variable of interest, eprescribing rates, was an ecological measure that did not allow determination of which
patients were seen by providers that used e-prescribing functionalities. Lastly, this study
was limited to only counties within 5 states and the inherent differences among these
counties when compared to other counties in the U.S. may limit the generalizability of
these findings.
Conclusion
While the current study did not find an association between the change in eprescribing rates and the change in ADE hospitalization rates among older adults, it may
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be too early to determine whether technologies are having a population health impact. As
we continue to invest time and funding to the implementation of HITs, additional
research and monitoring is necessary to determining whether a population-level benefit is
being established.
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CHAPTER 6
CONCLUSION
The U.S. healthcare system has focused on improving patient safety and the
quality of healthcare provision for over two decades. Implementation of health
information technologies and their use in improving patient safety have been of great
interest to health services researchers. This dissertation research examined the association
between the county-level rate of electronic prescribing, a type of health information
technology, and county-level rates of adverse drug events hospitalizations among older
adults.
Manuscripts one and two, represented as Chapters 4 and 5 of this document, were
based on the analysis of 2008 and 2011 Healthcare Cost and Utilization Project State
Inpatient Databased, the Office of the National Coordination Health IT Dashboard –
Health IT Adoption and Use dataset, and the Health Resources and Services
Administration (HRSA) Area Health Resource File (AHRF). Chapter 4 used a crosssectional ecological- and discharge- level analysis to determine the association between
county e-prescribing rates and ADE hospitalizations in 2011, and the odds that a
discharge would be ADE-associated versus other causes in 2011, respectively. Chapter 5
examined whether increased in the proportion of physicians using e-prescribing
technologies in a county were associated with decreased in the hospitalization rate for
ADEs among patients aged 65 years and older.
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Results from chapter 4 indicated that county e-prescribing rates were not 1)
significantly associated with county ADE hospitalization rates; 2) a significant factor in
determining the odds of an ADE hospitalization. Similarly, chapter 5 results found that
changes in e-prescribing rates at the county-level were not associated with the change in
ADE hospitalization rates.
While we hypothesized that the rate of e-prescribing would be associated with
decreases in ADE hospitalization rates, we believe several factors may have inhibited our
ability to detect such a difference. First, the rate of e-prescribing nationally for studied
counties was approximately 37%. A low adoption rate would categorize these adopters as
the “early majority” in Rogers’ Diffusion of Innovation theory (1995). These early
adopters may be limited in their ability to obtain short-term benefits due to their focus on
adapting technologies to improve long-term efficiencies. Second, we limited our analysis
to ADE hospitalizations because of their ability to provide insight into the safety of
ambulatory prescribing. However, the definition used did not allow for the identification
of preventable, potential, and non-preventable ADE hospitalizations. Preventable and
potential ADEs, in particular, have been shown to improve with the use of health
information technologies. Third, we were unable to control for patient-level
characteristics, such as number and type of chronic conditions, which may impact the
types of medications taken and the usefulness of the technology to prevent ADEs. Lastly,
we used an ecological measure for e-prescribing rates. This limited our ability to
determine whether a patient with an ADE hospitalization was seen at a practice with eprescribing capabilities.
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Though our results were not able to identify a significant association between eprescribing rates and ADE hospitalization rates, we believe further research and
monitoring is necessary to determine the potential impact of e-prescribing on populationlevel patient safety indicators. As we continue to increase federal funding towards the
implementation of technologies in healthcare, we must demonstrate a population-level
benefit.
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APPENDIX A
Description of hospitals excluded from analysis with missing hospital county data

State

Hospital
ID

Total
number of Likely
discharges FIPS
from
code
hospital

MED1078
MED0002
MED4271
MED4385
MED1576
MED4019

447
384
2265
2126
1100
399

04005
04013
04013
04013
04013
04017

00111520

12

11001

FL

00104018
00100197
00110047
00110051
23960083

2648
472
1035
710
3478

12069
12086
12095
12095
12095

AZ

MED3555
23960061
00111526
00104018
00110044
23960083
00110047
00110051
00110022
00110036
00223

27
709
43
2085
854
79
631
539
1543
74
12

04013
12031
12033
12069
12073
12095
12095
12095
12111
12103
34005

AZ

FL

NJ

Percent of
hospital
discharges
from likely
FIPS code (#
discharges)
2011
49.9 (223)
5.5 (21)
84.0 (1903)
84.5 (1797)
7.1 (78)
75.2 (300)
33.3 (4)
70.4 (1865)
79.2 (374)
42.9 (444)
19.4 (138)
39.9 (1388)
2008
85.2 (23)
57.8 (410)
44.2 (19)
75.9 (1582)
45.8 (391)
58.2 (46)
47.9 (302)
23.8 (128)
37.1 (573)
5.41 (4)
50.0 (6)
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Percent of
discharges in
county by this
hospital

Percent of
hospital
discharges
missing
patient
county of
residence

4.2
0.1
0.5
0.4
0.2
2.7
(only county
from FL was
for 1
discharge)
5.2
0.1
0.7
0.4
2.3

35.6
3.1
0.13
0.38
3.4
4.5

0.005
0.6
0.1
4.5
3.7
0.05
0.4
0.4
4.2
0.6
0.02

0
0.42
0
0
11.2
0
9.4
0.37
0.39
2.7
0

0
2.0
0
0.5
0.42
0.32

